Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ABI3BP "DKFZP586L2024, NESHBP, TARSH" ENSG00000154175 "ABI family member 3 binding protein" Q7Z7G0 3 100749156-100993515 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 53.6;Club cells: 70.5;Leydig cells: 90.0;Muller glia cells: 112.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 48.4;hTEC/SVTERT24-B: 86.0;hTERT-HME1: 87.3;HUVEC TERT2: 35.5;TIME: 187.0" "Group enriched" "Detected in many" 4 "amygdala: 4.0;basal ganglia: 15.3;cerebellum: 5.8;cerebral cortex: 13.1;olfactory region: 13.7" "Low region specificity" "Detected in all" HPA044127 Uncertain "Secreted in other tissues" NA NA 570000000 "HPA044127: AB_2678823" "unprognostic (4.32e-2)" "unprognostic (3.32e-2)" "unprognostic (6.36e-2)" "unprognostic (3.41e-1)" "unprognostic (1.70e-1)" "unprognostic (7.20e-2)" "unprognostic (7.58e-2)" "unprognostic (6.25e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-1)" "unprognostic (1.08e-1)" "unprognostic (9.46e-2)" "prognostic favorable (6.14e-4)" "unprognostic (2.27e-2)" "unprognostic (2.69e-2)" "unprognostic (6.59e-2)" "unprognostic (1.07e-3)" 35.3 5.2 2.7 24.7 9.0 0.0 16.1 1.2 3.3 45.0 15.8 9.7 6.9 1.7 29.4 23.6 23.4 16.9 44.1 28.1 4.2 2.9 6.6 2.2 34.5 8.2 4.4 3.6 33.5 3.8 0.5 4.3 45.8 4.7 23.0 19.4 80.6 10.5 4.2 8.7 9.8 10.2 39.2 8.0 3.8 22.3 12.3 5.3 0.2 23.2 23.7 25.3 38.5 19.1 0.7 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 4.5 48.4 0.0 9.9 9.7 18.2 8.6 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.1 28.9 0.0 0.0 0.2 0.1 0.0 2.5 0.0 0.0 2.8 0.1 86.0 87.3 0.3 35.5 0.0 0.0 0.1 15.8 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 187.0 3.9 0.0 32.9 1.9 0.1 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 9.0 1.2 2.4 4.2 2.9 4.4 3.6 4.7 5.3 53.6 5.6 0.0 1.5 14.2 1.0 10.3 2.5 5.3 70.5 17.4 2.0 0.5 0.0 0.0 7.2 9.0 0.0 0.0 0.3 0.6 43.8 1.1 3.5 0.0 0.8 0.0 1.2 11.1 1.2 7.8 90.0 2.9 18.6 0.0 0.5 112.5 1.1 4.5 26.2 6.5 3.5 0.0 18.6 0.1 0.2 17.3 0.6 0.0 0.6 2.5 ADAMTSL2 KIAA0605 ENSG00000197859 "ADAMTS like 2" Q86TH1 9 133532164-133575519 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 30.4;heart muscle: 36.4" "Cell type enhanced" "Detected in some" 9 "Distal tubular cells: 5.0;Intestinal endocrine cells: 5.1;Ito cells: 8.0;Leydig cells: 4.4;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Hep G2: 5.9;RPMI-8226: 8.2;SH-SY5Y: 25.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA045634, HPA053812" Approved Approved Vesicles "Secreted in other tissues" NA NA 67000000 Vesicles "HPA045634: AB_2679399, HPA053812: AB_2682271" "unprognostic (5.10e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (5.01e-4)" "unprognostic (8.35e-2)" "unprognostic (1.07e-1)" "unprognostic (5.50e-2)" "unprognostic (6.78e-3)" "unprognostic (1.31e-2)" "unprognostic (5.49e-2)" "unprognostic (1.35e-1)" "prognostic favorable (6.70e-4)" "unprognostic (5.17e-2)" "unprognostic (7.37e-2)" "unprognostic (1.56e-1)" "unprognostic (3.40e-1)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" 3.6 30.4 5.5 1.8 5.4 0.7 0.9 6.4 9.3 1.6 1.6 8.8 0.9 2.4 1.9 4.9 1.8 1.8 11.0 36.4 4.7 4.0 15.1 24.8 11.3 6.8 5.7 4.9 6.9 7.9 1.4 8.6 2.6 9.9 4.3 1.1 4.5 5.4 3.8 5.5 0.9 2.6 1.8 5.1 3.5 2.3 3.2 6.8 0.0 6.5 1.3 1.3 2.2 6.0 0.3 0.2 1.0 0.2 0.4 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.5 0.4 0.0 0.9 0.6 8.2 0.0 0.0 1.2 25.7 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.3 0.7 0.3 0.8 0.4 0.0 0.2 0.0 0.3 5.5 5.4 6.4 9.3 4.7 4.0 5.7 4.9 9.9 6.8 0.0 0.3 0.0 0.1 0.1 1.8 2.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.3 0.0 1.6 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.9 0.2 0.0 5.1 8.0 0.0 0.7 4.4 0.2 0.0 0.0 0.0 0.2 0.2 0.0 2.8 0.6 0.3 6.5 1.6 0.0 0.2 0.3 0.0 0.0 0.7 0.1 ADAMTSL3 "KIAA1233, punctin-2" ENSG00000156218 "ADAMTS like 3" P82987 15 83654086-84039842 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 131.0;Alveolar cells type 2: 92.7;Ciliated cells: 103.1;Club cells: 111.5;granulocytes: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 12.3;hTERT-RPE1: 3.7;RPTEC TERT1: 14.3;TIME: 13.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA034773, HPA034774" Uncertain Uncertain Vesicles "Secreted in other tissues" NA NA 110000 Vesicles "HPA034773: AB_10601965, HPA034774: AB_2674326" "unprognostic (2.20e-1)" "unprognostic (1.37e-1)" "unprognostic (2.98e-2)" "unprognostic (1.07e-2)" "unprognostic (1.56e-1)" "unprognostic (9.89e-2)" "unprognostic (4.07e-2)" "unprognostic (3.27e-1)" "unprognostic (9.18e-3)" "unprognostic (5.92e-2)" "unprognostic (9.97e-2)" "unprognostic (3.85e-1)" "unprognostic (8.59e-3)" "unprognostic (5.00e-3)" "unprognostic (4.62e-1)" "unprognostic (8.64e-2)" "unprognostic (3.95e-5)" 6.9 5.0 1.5 6.2 2.9 0.0 5.3 2.8 2.8 8.7 14.3 4.4 1.8 1.5 12.0 3.7 5.4 5.6 4.7 15.9 3.1 1.3 3.8 12.1 10.6 1.5 5.1 2.9 2.0 12.9 1.1 2.6 12.0 7.2 8.1 3.7 19.9 4.7 8.7 2.6 2.2 3.1 26.8 3.6 2.0 7.5 2.9 4.2 0.2 4.6 2.2 0.5 8.0 13.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.9 0.0 14.3 0.0 0.0 0.0 0.2 0.2 0.0 1.4 0.0 0.0 13.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.9 2.8 2.8 3.1 1.3 5.1 2.9 7.2 4.2 131.0 92.7 0.0 4.4 6.3 0.1 6.1 0.0 103.1 111.5 1.8 0.0 0.1 0.0 0.4 12.0 3.6 0.0 0.0 1.9 0.1 1.6 1.8 58.1 8.6 0.2 6.4 0.0 1.3 0.6 13.4 45.8 0.6 0.0 0.0 0.0 0.0 1.5 0.0 15.9 0.6 0.2 25.8 0.5 1.8 1.3 1.0 0.1 0.0 0.0 1.7 AGRP "Agrt, ART, ASIP2" ENSG00000159723 "Agouti related neuropeptide" O00253 16 67482571-67483813 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.4;epididymis: 49.8" "Group enriched" "Detected in some" 6 "Distal tubular cells: 3.3;Hofbauer cells: 9.2;Leydig cells: 2.8;Peritubular cells: 2.5" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 13 "hypothalamus: 19.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 2.6;CAPAN-2: 2.8;HeLa: 1.5;Hep G2: 2.2;HMC-1: 1.8" "Region enriched" "Detected in single" 16 "hypothalamus: 18.9" "Region enhanced" "Detected in many" "hypothalamus: 3.9" HPA041017 Enhanced Supported "Secreted in other tissues" NA NA 255000 "HPA041017: AB_10795498" "unprognostic (1.32e-1)" "unprognostic (6.26e-2)" "unprognostic (1.13e-1)" "unprognostic (4.16e-1)" "unprognostic (3.15e-1)" "unprognostic (1.10e-1)" "unprognostic (3.61e-1)" "unprognostic (3.34e-1)" "unprognostic (4.68e-1)" "unprognostic (1.29e-1)" "unprognostic (6.74e-2)" "unprognostic (3.17e-1)" "unprognostic (2.80e-1)" "unprognostic (1.72e-1)" "unprognostic (5.63e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-2)" 0.1 9.6 0.1 0.1 1.4 0.0 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.1 49.8 0.1 0.0 0.1 0.1 0.1 19.4 0.5 0.1 2.1 0.3 0.1 0.3 0.1 0.1 0.0 0.4 0.1 0.2 0.1 0.0 0.3 0.5 0.1 0.1 0.4 0.1 0.1 0.3 0.3 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.2 2.1 1.4 3.8 0.3 3.2 1.0 0.1 0.0 0.4 1.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.6 2.8 0.8 0.2 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.4 1.5 2.2 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.2 0.0 1.5 0.1 1.0 0.0 0.0 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.2 0.0 0.1 1.0 0.5 1.0 0.0 0.4 0.3 0.0 3.8 1.4 3.2 2.3 1.6 2.2 0.8 1.1 1.5 1.9 2.1 2.2 0.6 0.3 1.2 2.1 1.3 1.0 0.1 1.4 0.1 0.2 0.1 19.4 0.1 0.3 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 ANGPTL5 ENSG00000187151 "Angiopoietin like 5" Q86XS5 11 101890674-101916522 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 9.4;ovary: 24.9" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 5.6;Leydig cells: 25.6;Melanocytes: 6.8;Peritubular cells: 14.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "ASC diff: 7.9;ASC TERT1: 2.2" "Low region specificity" "Detected in all" HPA038516 Uncertain "Secreted in other tissues" NA NA "HPA038516: AB_10672749" "unprognostic (8.28e-3)" "unprognostic (3.08e-2)" "unprognostic (1.21e-1)" "unprognostic (2.62e-1)" "unprognostic (3.23e-2)" "unprognostic (2.18e-1)" "unprognostic (4.88e-2)" "unprognostic (6.74e-4)" "unprognostic (1.96e-1)" "unprognostic (1.53e-8)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (1.94e-1)" "unprognostic (3.17e-3)" 9.4 0.3 0.2 0.0 0.3 0.0 6.4 0.2 0.7 1.3 0.3 0.0 0.6 0.1 0.1 5.0 1.0 0.4 0.3 3.7 0.2 0.2 0.1 0.2 1.0 0.1 2.0 0.5 24.9 0.0 0.0 0.3 0.1 0.8 1.4 0.2 0.0 0.5 0.3 1.9 3.5 0.5 1.3 1.7 0.0 0.2 6.2 0.3 0.2 2.4 2.9 0.0 1.8 1.1 0.7 1.0 0.0 0.0 0.9 0.3 0.0 0.0 0.1 0.0 0.0 7.9 2.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.9 0.0 1.0 0.0 0.0 0.2 0.3 0.2 0.7 0.2 0.2 2.0 0.5 0.8 0.3 0.0 0.0 0.0 0.0 5.6 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 25.6 0.0 6.8 0.0 0.0 0.2 0.0 0.0 14.2 0.0 0.3 0.0 1.4 0.2 0.0 4.8 0.1 0.0 0.0 0.0 ANGPTL7 "AngX, CDT6" ENSG00000171819 "Angiopoietin like 7" O43827 1 11189341-11195981 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 22.9" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Cardiomyocytes: 2.2;granulocytes: 1.1;Intestinal endocrine cells: 1.7;Melanocytes: 3.3" "Cancer enriched" "Detected in some" 14 "melanoma: 18.4" "Region enriched" "Detected in single" 6 "cerebellum: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 62 "SCLC-21H: 31.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "Secreted in other tissues" NA NA 490000 "unprognostic (3.23e-2)" "unprognostic (6.95e-2)" "unprognostic (1.22e-1)" "unprognostic (2.67e-3)" "unprognostic (2.87e-3)" "unprognostic (2.80e-1)" "unprognostic (4.89e-2)" "unprognostic (2.02e-1)" "unprognostic (1.10e-1)" "unprognostic (3.97e-1)" "unprognostic (1.10e-1)" "unprognostic (1.58e-2)" "unprognostic (3.41e-3)" "unprognostic (1.92e-1)" "unprognostic (1.19e-3)" "unprognostic (2.49e-2)" 12.8 3.7 0.1 2.0 0.2 0.0 4.8 3.2 0.2 5.4 8.0 0.3 9.3 1.3 1.4 4.3 7.0 1.7 5.9 10.4 0.1 0.3 6.5 0.4 2.1 1.0 0.1 0.4 1.9 0.6 0.0 7.8 0.9 0.5 4.7 2.4 5.3 4.2 11.4 22.9 5.9 2.6 16.5 3.5 0.4 2.2 3.9 0.5 0.1 0.7 13.8 1.4 6.2 4.5 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.2 0.2 0.1 0.3 0.1 0.4 0.5 0.5 3.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPIFC "BPIL2, dJ149A16.7" ENSG00000184459 "BPI fold containing family C" Q8NFQ6 22 32413847-32464484 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "skin 1: 39.5;tongue: 16.4" "Group enriched" "Detected in some" 32 "Early spermatids: 16.4;Late spermatids: 6.5;Suprabasal keratinocytes: 4.1" "Group enriched" "Detected in some" 11 "head and neck cancer: 1.6;melanoma: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 56 "basophil: 5.5" "Lineage enriched" "Detected in single" 56 "granulocytes: 5.5" "Group enriched" "Detected in some" 5 "HDLM-2: 3.4;hTCEpi: 1.7;SCLC-21H: 4.7;U-87 MG: 2.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (2.74e-1)" "unprognostic (3.48e-3)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (2.58e-1)" "unprognostic (3.48e-2)" "unprognostic (2.74e-1)" "unprognostic (2.58e-1)" "unprognostic (2.76e-3)" "unprognostic (1.41e-2)" "unprognostic (2.80e-1)" 0.0 0.0 0.4 0.0 0.5 0.0 2.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 39.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.0 16.4 0.8 0.0 0.4 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.5 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 4.1 0.0 0.0 0.0 0.0 C3orf58 "DIA1, HASF, MGC33365" ENSG00000181744 "Chromosome 3 open reading frame 58" Q8NDZ4 3 143971798-144048719 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 86.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048992 Approved "Secreted in other tissues" NA NA "HPA048992: AB_2680591" "unprognostic (5.96e-2)" "unprognostic (8.54e-2)" "unprognostic (1.17e-1)" "unprognostic (2.24e-1)" "unprognostic (2.43e-1)" "unprognostic (2.85e-2)" "unprognostic (3.74e-2)" "unprognostic (2.31e-2)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (3.44e-1)" "unprognostic (3.98e-1)" "prognostic unfavorable (2.92e-7)" "unprognostic (4.82e-3)" "unprognostic (2.87e-1)" "unprognostic (1.70e-1)" "unprognostic (1.50e-2)" 9.1 6.0 12.4 7.8 15.5 21.5 13.4 27.5 15.3 11.7 9.3 21.9 5.0 5.2 11.5 4.9 12.1 10.4 11.4 9.0 13.2 10.9 5.6 15.0 10.1 9.1 16.5 10.9 16.8 7.3 11.3 5.0 29.3 10.6 9.6 7.2 5.4 7.6 10.7 4.2 19.0 6.7 12.2 14.5 7.9 8.2 6.0 18.4 10.9 10.2 4.7 8.3 11.6 12.5 6.8 11.9 16.0 9.4 7.4 5.2 4.1 9.4 3.8 9.9 58.5 9.2 8.4 5.4 6.9 6.7 6.6 7.1 2.6 3.8 5.9 5.4 2.6 4.7 5.4 14.6 5.6 10.4 2.8 5.3 8.8 3.9 3.8 4.0 8.0 4.1 6.9 3.0 4.0 6.2 6.7 10.2 2.7 1.5 17.4 8.3 2.5 2.9 3.9 6.2 3.9 2.4 4.3 5.1 6.6 4.0 11.3 6.6 0.0 4.9 2.3 2.2 2.8 6.1 4.4 4.8 5.9 2.8 9.1 7.9 7.0 2.4 8.7 9.5 3.8 7.5 16.0 9.4 15.5 3.0 6.1 5.2 6.6 3.6 3.2 11.9 6.8 3.2 3.0 2.8 7.4 7.8 7.4 3.1 4.1 12.4 15.5 27.5 15.3 13.2 10.9 16.5 10.9 10.6 18.4 86.4 8.1 22.3 12.5 31.7 3.6 13.2 28.1 14.7 15.9 5.2 23.6 1.1 0.0 5.8 2.9 24.3 8.9 23.3 4.8 1.5 32.1 15.1 18.4 16.6 18.6 9.5 32.1 16.0 26.2 3.2 16.4 18.5 21.9 3.6 8.4 30.9 3.4 13.5 18.0 2.8 6.3 19.4 23.9 2.7 17.3 26.6 2.9 10.1 9.4 6.3 C5orf46 "MGC23985, SSSP1" ENSG00000178776 "Chromosome 5 open reading frame 46" Q6UWT4 5 147880726-147906538 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "salivary gland: 107.9;skin 1: 42.7" "Group enriched" "Detected in some" 7 "Early spermatids: 262.3;Late spermatids: 107.1" "Cancer enhanced" "Detected in many" "renal cancer: 8.3" "Region enriched" "Detected in single" 5 "cerebellum: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 23.8;PC-3: 39.1;SiHa: 8.7;U-2 OS: 25.5;U-251 MG: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058999, HPA079692" Supported Approved "Nuclear speckles,Mitochondria" "Secreted in other tissues" NA NA "Nuclear speckles" Mitochondria "HPA058999: , HPA079692: " "unprognostic (1.72e-1)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.26e-4)" "unprognostic (9.75e-3)" "unprognostic (2.95e-3)" "unprognostic (1.69e-3)" "unprognostic (1.99e-2)" "unprognostic (3.08e-2)" "unprognostic (2.22e-1)" "unprognostic (4.96e-2)" "unprognostic (2.86e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.75e-9)" "unprognostic (6.48e-3)" "unprognostic (3.47e-2)" "unprognostic (6.01e-2)" "unprognostic (2.79e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 5.2 2.0 0.1 0.6 0.1 0.1 0.1 0.0 0.3 0.6 0.2 0.0 0.2 3.0 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.3 0.6 0.0 0.1 4.3 0.4 0.4 0.0 0.2 107.9 0.4 0.6 42.7 0.1 1.0 0.1 0.1 0.0 6.5 0.2 0.2 0.1 1.1 0.6 0.2 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 4.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.7 0.1 0.1 5.1 0.0 0.0 0.0 4.6 25.5 0.3 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.0 0.1 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.5 0.0 8.7 25.5 0.0 0.0 1.8 0.0 0.1 0.0 12.4 262.3 0.0 0.0 0.0 2.9 0.1 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 107.1 1.7 0.0 3.3 1.0 0.0 6.7 4.3 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.8 18.1 1.1 0.0 0.0 0.1 CDSN D6S586E ENSG00000204539 Corneodesmosin 6 31115090-31120446 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 19.2;skin 1: 109.3;tongue: 29.7" "Group enriched" "Detected in some" 6 "granulocytes: 4.6;Suprabasal keratinocytes: 4.5" "Group enriched" "Detected in some" 8 "head and neck cancer: 2.4;melanoma: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "A-431: 5.9" "Group enriched" "Detected in some" 5 "amygdala: 1.0;cerebral cortex: 1.5;hippocampal formation: 1.0" "Not detected" "Not detected" "HPA044730, HPA054184" Enhanced "Secreted in other tissues" NA NA "HPA044730: AB_10964923, HPA054184: AB_2682409" "unprognostic (1.46e-1)" "unprognostic (6.96e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-1)" "unprognostic (3.44e-2)" "unprognostic (8.80e-2)" "unprognostic (8.13e-2)" "unprognostic (3.92e-4)" "unprognostic (3.92e-3)" "unprognostic (1.74e-4)" "unprognostic (6.34e-2)" "unprognostic (2.75e-1)" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 109.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 29.7 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.1 CEACAM16 DFNA4B ENSG00000213892 "Carcinoembryonic antigen related cell adhesion molecule 16" Q2WEN9 19 44699151-44710714 "Disease related genes, Predicted secreted proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.9;pancreas: 7.0" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 1.1;Rod photoreceptor cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.2;RH-30: 1.5;T-47d: 2.8;U-266/70: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045075 Uncertain "Secreted in other tissues" NA NA "HPA045075: AB_10959617" "unprognostic (1.27e-1)" "unprognostic (3.73e-1)" "unprognostic (3.12e-1)" "unprognostic (3.32e-2)" "unprognostic (4.72e-1)" "unprognostic (1.42e-2)" "unprognostic (7.76e-2)" "unprognostic (3.59e-2)" "unprognostic (7.81e-3)" "unprognostic (3.88e-2)" "unprognostic (2.05e-1)" "unprognostic (1.06e-1)" "unprognostic (1.86e-1)" "unprognostic (7.94e-2)" 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 7.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.7 0.0 0.0 0.0 0.0 5.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 CGB2 ENSG00000104818 "Chorionic gonadotropin beta subunit 2" 19 49031912-49033238 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.1;testis: 4.1" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 33.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HMC-1: 25.4;U-266/70: 10.2;U-266/84: 12.3" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (3.05e-2)" 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 1.1 1.0 0.9 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.1 1.4 0.4 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.1 0.3 4.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 3.4 0.0 0.4 0.0 0.0 0.1 0.0 25.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.7 0.0 3.0 10.2 12.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 6.5 0.0 0.5 1.1 0.0 33.4 0.0 0.0 0.0 CGB7 CG-beta-a ENSG00000196337 "Chorionic gonadotropin beta subunit 7" P0DN87 19 49054275-49058860 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 8.1" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 49.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.1;HaCaT: 5.7;HBEC3-KT: 4.8;hTCEpi: 6.9;U-251 MG: 10.4" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (9.53e-2)" "unprognostic (1.99e-1)" "unprognostic (1.87e-1)" "unprognostic (3.53e-1)" "unprognostic (4.60e-5)" "unprognostic (2.64e-1)" "unprognostic (2.46e-1)" "unprognostic (8.37e-2)" "unprognostic (2.88e-2)" "unprognostic (4.80e-2)" "unprognostic (8.83e-4)" "unprognostic (1.54e-1)" "unprognostic (3.89e-8)" "unprognostic (1.63e-2)" "unprognostic (1.94e-1)" "unprognostic (2.05e-1)" "unprognostic (9.28e-2)" 0.3 0.2 0.3 0.3 0.3 0.0 0.8 0.3 1.5 1.7 0.3 0.3 3.7 0.3 1.2 0.5 4.0 1.0 2.0 2.0 0.4 0.2 1.0 0.3 0.8 0.3 0.3 0.3 0.9 2.5 0.0 2.7 3.7 1.3 4.6 0.0 0.8 1.3 3.9 6.4 8.1 0.3 0.3 0.3 0.3 0.0 1.5 0.3 0.3 0.9 2.2 0.3 2.4 2.7 0.2 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.8 0.2 1.5 0.0 0.2 7.1 0.6 0.0 1.4 1.2 1.2 2.6 0.0 0.1 1.3 2.1 5.7 0.2 4.8 0.5 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.4 6.9 0.4 0.7 1.6 0.0 0.0 0.0 0.2 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.0 0.1 0.1 1.4 0.1 0.1 1.7 1.0 0.2 0.2 2.3 2.3 0.0 10.4 0.3 0.4 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.3 1.5 0.4 0.2 0.3 0.3 1.3 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 49.1 0.0 0.0 0.0 CLUL1 ENSG00000079101 "Clusterin like 1" Q15846 18 596988-650334 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 45.2" "Cell type enriched" "Detected in many" 7 "Rod photoreceptor cells: 335.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 24.6" "Not detected" "Not detected" "CAB025264, HPA075240" Enhanced Approved "Endoplasmic reticulum,Plasma membrane" "Secreted in other tissues" NA NA "Endoplasmic reticulum" "Plasma membrane" "CAB025264: , HPA075240: AB_2732286" "unprognostic (1.75e-2)" "unprognostic (9.15e-2)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (7.81e-3)" "unprognostic (3.00e-3)" "unprognostic (1.96e-1)" "unprognostic (2.97e-3)" "unprognostic (8.38e-3)" "unprognostic (3.76e-2)" "unprognostic (4.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.36e-4)" "unprognostic (1.32e-1)" "unprognostic (7.89e-2)" "unprognostic (1.29e-3)" "unprognostic (2.37e-2)" 0.5 1.4 5.0 0.5 3.8 4.3 3.1 4.5 6.6 2.1 1.0 1.4 1.0 0.6 1.9 0.7 1.6 2.4 2.5 0.4 5.9 6.4 7.5 0.7 1.8 0.8 4.9 2.0 7.4 1.6 2.5 6.1 0.7 5.1 12.0 0.0 45.2 3.1 1.6 0.1 0.8 1.7 0.4 5.3 0.1 3.9 3.4 2.8 0.3 9.4 0.1 0.4 2.1 0.3 1.0 1.3 2.1 0.3 0.1 2.0 0.5 2.6 3.9 7.5 5.1 0.0 0.0 4.5 2.9 0.2 0.0 0.0 3.1 1.5 3.1 0.7 0.0 2.7 1.1 0.0 0.4 0.0 2.5 7.0 5.2 2.1 24.6 0.0 1.7 1.0 0.2 0.0 0.0 0.0 1.3 0.3 7.7 7.3 9.1 0.0 0.8 3.1 5.6 0.5 3.2 1.8 6.3 3.5 11.0 0.8 0.8 6.6 4.6 2.9 1.8 2.2 6.3 2.4 0.8 0.6 3.0 4.4 2.1 1.4 5.2 9.1 6.5 2.4 3.4 2.6 0.9 0.3 0.2 0.2 0.0 0.1 1.0 0.4 0.2 0.5 0.1 0.1 0.8 2.1 0.1 0.0 1.3 2.0 0.5 5.0 3.8 4.5 5.7 5.9 6.4 4.9 2.0 5.1 2.8 0.0 1.6 0.0 3.4 0.0 23.9 0.1 0.0 4.0 2.3 0.0 19.6 0.4 1.7 0.2 0.4 0.2 0.0 0.0 0.2 0.1 0.1 8.5 0.0 0.0 0.2 15.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 46.9 0.0 0.0 1.1 0.3 335.8 6.5 0.0 8.4 4.5 0.1 0.3 0.0 0.0 1.4 COL6A5 "COL29A1, FLJ35880, VWA4" ENSG00000172752 "Collagen type VI alpha 5 chain" 3 130345516-130484844 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lung: 9.6;skin 1: 11.1" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 3.1;Club cells: 1.2;Early spermatids: 4.1;Late spermatids: 2.4;Suprabasal keratinocytes: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 63 "HDLM-2: 18.8" "Region enhanced" "Detected in single" "hypothalamus: 1.2" "Not detected" "Not detected" HPA043138 Uncertain "Secreted in other tissues" NA NA "HPA043138: AB_10796687" "unprognostic (3.45e-2)" "unprognostic (4.08e-2)" "unprognostic (6.01e-3)" "unprognostic (2.32e-1)" "unprognostic (3.42e-2)" "unprognostic (1.46e-6)" "unprognostic (8.44e-2)" "unprognostic (2.07e-3)" "unprognostic (2.47e-1)" "unprognostic (1.71e-1)" "unprognostic (7.58e-8)" "unprognostic (3.85e-2)" "unprognostic (4.51e-1)" "unprognostic (1.54e-1)" "unprognostic (2.79e-2)" 0.2 0.0 0.2 0.2 0.5 0.1 1.0 0.2 0.2 0.2 0.4 0.2 0.2 1.5 0.2 0.2 2.1 0.0 0.2 0.2 0.2 0.2 0.2 0.2 9.6 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 11.1 1.8 0.2 0.2 0.2 1.5 1.1 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 3.1 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 3.0 0.0 0.0 0.0 0.0 CRISP3 "Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28" ENSG00000096006 "Cysteine rich secretory protein 3" P54108 6 49727384-49744437 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 156.3;fallopian tube: 117.6;salivary gland: 233.3" "Group enriched" "Detected in some" 8 "Cholangiocytes: 38.2;Club cells: 23.9;Melanocytes: 21.9" "Group enriched" "Detected in many" 7 "breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 45 "neutrophil: 6.0;non-classical monocyte: 2.9" "Group enriched" "Detected in many" 45 "granulocytes: 6.0;monocytes: 2.9" "Group enriched" "Detected in some" 20 "HEL: 14.5;RT4: 4.9;SK-BR-3: 11.0;T-47d: 5.4" "Not detected" "Not detected" HPA054392 Supported "Secreted in other tissues" NA NA 390000000 "HPA054392: AB_2682472" "unprognostic (1.28e-2)" "unprognostic (7.01e-2)" "unprognostic (8.93e-2)" "unprognostic (5.56e-2)" "unprognostic (1.02e-1)" "unprognostic (2.22e-4)" "unprognostic (5.30e-2)" "unprognostic (6.70e-2)" "unprognostic (9.16e-2)" "unprognostic (4.34e-3)" "unprognostic (1.91e-1)" "unprognostic (1.93e-1)" 0.2 0.2 0.2 0.0 0.2 33.5 0.2 0.2 0.2 11.1 0.2 0.0 156.3 0.0 0.7 0.0 45.3 117.6 2.0 0.2 0.2 0.2 0.2 0.2 0.6 0.0 0.2 0.0 15.9 1.7 0.0 0.2 0.0 0.0 3.0 0.0 0.0 233.3 17.7 0.2 0.6 0.2 0.0 0.2 0.4 0.2 0.2 0.0 0.0 0.2 56.7 14.8 1.2 14.4 0.0 0.0 6.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 11.0 0.0 0.0 5.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 2.9 0.0 0.0 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 38.2 2.7 23.9 3.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.4 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 CTHRC1 ENSG00000164932 "Collagen triple helix repeat containing 1" Q96CG8 8 103371515-103382997 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Endothelial cells: 36.6;Fibroblasts: 168.4;Melanocytes: 47.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 2.3;NK-cell: 5.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.3;NK-cells: 5.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 56.2;fHDF/TERT166: 24.7;HHSteC: 37.4;HSkMC: 77.1;WM-115: 70.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059806, HPA061896" Approved Approved Nucleoplasm "Secreted in other tissues" NA NA 320000 Nucleoplasm "HPA059806: AB_2684130, HPA061896: AB_2684633" "unprognostic (2.04e-2)" "unprognostic (4.58e-1)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.33e-2)" "prognostic unfavorable (1.67e-4)" "unprognostic (4.17e-2)" "unprognostic (3.64e-2)" "unprognostic (8.63e-2)" "unprognostic (1.12e-2)" "unprognostic (3.73e-2)" "prognostic unfavorable (1.22e-14)" "unprognostic (2.33e-3)" "unprognostic (3.21e-2)" "unprognostic (7.96e-3)" "unprognostic (2.37e-3)" 35.1 1.4 1.1 5.2 1.1 0.0 32.3 0.8 2.3 5.3 3.8 0.5 3.0 2.0 6.9 11.2 3.5 3.0 33.0 4.2 1.1 1.6 2.0 0.7 4.5 7.6 1.6 1.3 3.7 2.1 0.3 2.1 32.2 1.9 4.0 2.1 2.6 23.0 4.2 9.2 17.4 2.1 8.4 2.6 1.4 1.8 8.4 0.8 2.2 4.8 3.7 5.4 31.3 3.6 0.2 0.7 2.3 0.0 5.2 0.4 0.3 2.1 0.1 0.6 0.1 16.9 56.2 0.0 6.3 1.7 0.6 0.9 0.2 1.5 0.2 6.7 24.7 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.1 3.4 37.4 0.1 0.1 77.1 0.1 5.7 0.0 0.2 11.0 0.4 0.0 17.0 3.4 0.3 3.0 7.3 2.0 0.0 10.6 6.4 5.7 0.2 0.5 0.0 1.0 0.8 0.0 0.0 18.9 2.4 0.0 0.0 8.9 0.8 0.3 0.9 0.0 0.5 0.1 0.1 0.4 0.0 70.8 0.0 0.0 2.3 0.1 0.0 0.4 0.2 0.1 0.0 0.0 0.1 0.2 0.3 0.1 5.2 0.0 0.7 0.0 0.3 1.1 1.1 0.8 2.3 1.1 1.6 1.6 1.3 1.9 0.8 3.0 2.9 0.0 0.1 28.4 0.3 0.6 2.5 0.0 0.0 3.5 0.0 5.6 0.0 4.4 0.3 36.6 0.0 0.0 0.6 8.9 168.4 0.6 0.0 0.0 7.0 0.0 1.2 26.4 0.3 0.2 11.5 1.7 47.2 1.0 0.0 5.5 2.4 0.0 0.4 0.3 1.0 0.0 24.7 1.6 15.6 23.8 13.8 0.0 0.0 0.4 CYTL1 "C17, C4orf4" ENSG00000170891 "Cytokine like 1" Q9NRR1 4 5014586-5019472 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.2" "Cell type enhanced" "Detected in some" 12 "Endothelial cells: 8.3;Fibroblasts: 15.8;granulocytes: 9.2;Hofbauer cells: 12.7;Macrophages: 5.9;Melanocytes: 8.5" "Cancer enhanced" "Detected in many" "glioma: 21.0;melanoma: 20.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "NK-cell: 18.8" "Lineage enriched" "Detected in many" 10 "NK-cells: 18.8" "Cell line enhanced" "Detected in some" "HEL: 42.6;HUVEC TERT2: 34.2;NB-4: 83.4;WM-115: 20.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067201 Supported "Nuclear membrane,Endoplasmic reticulum" "Secreted in other tissues" NA NA "Nuclear membrane, Endoplasmic reticulum" "HPA067201: AB_2732760" "unprognostic (2.35e-2)" "unprognostic (9.01e-3)" "unprognostic (3.56e-1)" "unprognostic (3.76e-2)" "unprognostic (1.14e-1)" "unprognostic (2.71e-1)" "unprognostic (2.09e-2)" "unprognostic (1.44e-1)" "unprognostic (7.10e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (4.78e-2)" "prognostic unfavorable (7.43e-4)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.18e-1)" "unprognostic (3.07e-2)" "prognostic unfavorable (1.25e-4)" 5.2 2.3 6.5 2.0 6.0 10.8 6.4 0.7 4.2 11.0 4.9 9.2 4.9 1.0 10.1 2.8 5.3 7.3 4.6 4.4 5.4 4.4 1.2 0.8 17.1 9.4 6.2 2.1 2.5 1.1 1.7 1.6 42.2 4.7 10.5 1.8 4.5 4.0 14.2 0.8 3.3 2.1 4.2 11.0 1.1 4.9 2.2 8.4 0.5 5.7 3.6 4.8 13.2 7.4 0.0 0.3 1.9 1.0 18.8 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.6 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.6 0.0 0.0 34.2 0.0 0.0 1.7 0.0 0.0 0.0 83.4 0.1 0.0 0.0 1.2 1.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 5.2 0.0 0.0 0.0 11.7 0.0 8.1 0.0 0.0 0.2 0.0 0.0 0.0 1.0 20.2 1.9 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.6 0.1 18.8 0.0 0.3 0.0 0.6 6.5 6.0 0.7 4.2 5.4 4.4 6.2 2.1 4.7 8.4 0.0 0.3 0.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 8.3 0.0 0.0 0.0 0.1 15.8 0.5 9.2 0.0 12.7 0.0 0.0 1.3 0.0 0.0 0.0 5.9 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.5 0.0 0.0 0.6 DAND5 "CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3" ENSG00000179284 "DAN domain BMP antagonist family member 5" Q8N907 19 12965159-12974762 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.3;heart muscle: 13.7" "Cell type enriched" "Detected in single" 29 "Cardiomyocytes: 13.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 15 "SH-SY5Y: 21.0" "Low region specificity" "Detected in all" "HPA043493, HPA049472" Uncertain Approved Mitochondria "Secreted in other tissues" NA NA Mitochondria "HPA043493: AB_2732505, HPA049472: AB_2680781" "unprognostic (1.18e-2)" "unprognostic (4.63e-2)" "unprognostic (7.51e-2)" "unprognostic (4.63e-2)" "unprognostic (3.82e-2)" "unprognostic (8.71e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-1)" "unprognostic (5.95e-3)" "unprognostic (7.27e-3)" "unprognostic (8.17e-2)" "unprognostic (2.15e-1)" "unprognostic (2.48e-10)" "unprognostic (4.43e-1)" "unprognostic (2.48e-2)" "unprognostic (6.77e-2)" "unprognostic (1.37e-1)" 0.2 2.0 0.9 0.9 2.5 3.0 0.4 1.4 1.4 0.2 3.6 2.1 0.0 0.4 0.4 0.4 0.3 0.1 0.7 13.7 0.4 0.3 0.1 0.1 0.2 0.3 0.5 0.0 0.4 0.4 0.4 0.2 0.0 3.8 0.2 0.5 3.6 2.6 0.0 0.2 0.7 2.5 0.4 1.6 0.1 0.7 0.8 0.3 0.0 0.5 0.0 0.0 0.3 0.2 1.6 1.4 5.3 0.6 1.4 1.2 0.3 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.1 0.4 0.0 0.7 0.3 0.0 0.1 0.2 0.2 0.0 0.3 0.0 0.2 0.1 0.8 0.4 1.3 0.0 0.5 0.3 0.1 0.2 0.1 0.3 0.2 0.0 0.3 0.2 0.1 1.1 21.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.2 0.3 0.1 0.2 0.5 0.1 0.1 0.0 0.3 0.1 2.7 0.6 1.3 0.7 0.4 0.6 0.9 0.4 0.4 0.2 1.6 0.7 1.2 5.3 1.4 0.3 1.4 0.2 0.3 0.9 2.5 1.4 0.8 0.4 0.3 0.5 0.0 3.8 0.3 0.0 0.0 0.0 0.2 0.1 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 DMKN ZD52F10 ENSG00000161249 Dermokine Q6E0U4 19 35497220-35513658 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skin 1: 365.3" "Cell type enriched" "Detected in many" 5 "Suprabasal keratinocytes: 7442.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 9.5" "Cell type enhanced" "Detected in many" "NK-cell: 11.1" "Group enriched" "Detected in many" 5 "NK-cells: 11.1;T-cells: 7.0" "Cell line enhanced" "Detected in many" "A-431: 32.0;CACO-2: 39.6;CAPAN-2: 34.0;HBEC3-KT: 51.9;RPTEC TERT1: 51.3" HPA029406 Enhanced Approved Nucleoplasm,Cytosol "Secreted in other tissues" NA NA 29000000 "Nucleoplasm, Cytosol" "HPA029406: AB_10603661" "unprognostic (5.70e-2)" "unprognostic (2.36e-2)" "unprognostic (3.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-2)" "unprognostic (3.82e-2)" "unprognostic (3.23e-1)" "unprognostic (1.03e-1)" "unprognostic (8.82e-2)" "unprognostic (2.54e-1)" "unprognostic (9.93e-2)" "prognostic favorable (5.37e-6)" "unprognostic (3.50e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" 1.4 1.1 0.6 0.5 4.7 0.6 23.9 0.7 2.0 54.8 1.2 1.1 2.5 1.0 5.6 9.2 25.3 8.7 0.6 1.4 0.7 1.1 11.3 0.8 8.8 0.5 0.9 0.6 11.7 29.5 4.7 13.3 1.7 9.5 5.0 1.0 9.5 8.2 9.1 2.4 365.3 1.2 0.9 0.9 0.6 1.8 0.8 2.3 3.1 25.9 62.9 16.9 3.5 27.5 1.7 0.2 0.0 0.0 11.1 7.0 1.2 32.0 5.2 0.0 0.0 1.3 2.0 9.0 0.1 4.3 0.2 0.3 39.6 34.0 0.0 13.0 0.3 1.6 18.0 9.8 51.9 0.4 0.1 9.5 0.0 0.0 8.8 1.5 0.0 0.1 17.8 14.0 0.9 30.2 3.0 0.0 0.0 0.1 0.0 0.1 28.0 0.0 0.0 28.8 23.3 2.1 0.0 0.0 1.3 51.3 21.2 0.1 0.0 7.8 0.0 3.1 8.6 13.0 0.0 0.0 5.0 15.2 0.1 0.1 0.2 0.0 0.2 4.2 0.0 0.3 0.0 0.0 0.0 7.0 0.0 6.1 1.7 0.6 3.4 0.0 0.2 0.1 2.4 0.0 11.1 0.0 0.2 0.0 1.2 0.6 4.7 0.7 2.0 0.7 1.1 0.9 0.6 9.5 2.3 98.3 94.2 3.7 121.7 1442.2 1.4 15.2 94.3 261.0 92.1 193.7 0.0 0.7 195.6 125.9 15.0 6.0 1.3 0.0 120.1 1.1 57.3 55.5 7.0 2.0 1.0 0.0 47.4 5.5 0.8 67.8 12.0 5.1 290.1 4.6 4.2 9.3 137.6 5.8 14.9 4.4 0.7 0.0 14.2 7.1 16.4 7442.2 1.9 5.3 11.0 72.7 EMID1 "EMI5, EMU1, hEmu1" ENSG00000186998 "EMI domain containing 1" Q96A84 22 29205851-29259597 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.0" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 23.3;granulocytes: 11.5;Ito cells: 14.7" "Cancer enhanced" "Detected in all" "endometrial cancer: 23.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "NK-cell: 2.3" "Lineage enriched" "Detected in single" 8 "NK-cells: 2.3" "Group enriched" "Detected in some" 4 "HEL: 13.2;NB-4: 45.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000592 Uncertain "Secreted in other tissues" NA NA "HPA000592: AB_1078737" "unprognostic (2.20e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-2)" "unprognostic (7.80e-3)" "unprognostic (2.40e-2)" "unprognostic (1.42e-1)" "unprognostic (3.46e-1)" "unprognostic (6.25e-3)" "unprognostic (3.75e-2)" "unprognostic (2.33e-1)" "unprognostic (5.24e-3)" "unprognostic (1.18e-1)" "unprognostic (1.36e-3)" "unprognostic (1.59e-1)" "unprognostic (1.76e-1)" "unprognostic (3.09e-2)" "unprognostic (1.08e-1)" 2.6 19.3 17.8 3.6 12.7 11.7 2.4 3.5 17.9 2.9 5.4 14.2 2.2 4.8 10.5 2.5 0.9 10.4 4.8 1.3 12.6 6.1 7.7 2.1 7.0 13.3 5.6 14.7 4.8 12.7 4.5 1.2 4.7 3.8 5.2 3.4 2.9 4.7 4.2 0.7 3.6 7.4 2.3 2.6 31.0 7.0 2.1 6.9 4.6 8.4 0.5 2.2 5.0 1.4 0.1 0.0 0.0 0.0 2.3 0.3 0.1 0.0 0.1 2.3 4.9 0.0 0.0 0.3 0.0 0.0 0.2 0.1 2.6 0.3 0.0 2.2 0.0 0.0 0.0 1.2 0.0 0.0 5.2 4.1 13.2 0.0 0.5 0.3 1.8 1.0 0.1 0.1 0.1 0.0 0.0 0.0 3.0 1.1 0.0 0.0 3.6 0.1 45.9 0.5 0.0 0.2 0.0 0.1 5.0 0.0 0.0 6.3 3.0 0.2 0.0 0.0 0.4 1.9 2.4 0.0 0.0 3.9 0.0 0.0 0.2 0.0 0.0 0.0 6.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 17.8 12.7 3.5 17.9 12.6 6.1 5.6 14.7 3.8 6.9 0.0 4.5 0.0 0.8 2.5 0.1 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 0.1 2.2 0.0 23.3 1.2 0.1 3.1 2.4 11.5 0.2 0.3 0.0 0.0 14.7 0.8 0.2 2.8 0.0 0.0 1.0 0.0 1.2 0.7 0.0 1.8 1.4 0.5 0.0 2.8 0.0 1.5 1.8 0.2 0.5 0.0 0.4 FAM19A3 "TAFA-3, TAFA3" ENSG00000184599 "Family with sequence similarity 19 member A3, C-C motif chemokine like" Q7Z5A8 1 112720419-112727235 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "adrenal gland: 19.6;brain: 5.2;testis: 8.8" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 44.6;Cone photoreceptor cells: 64.8;Muller glia cells: 15.8;Rod photoreceptor cells: 17.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.7;BJ hTERT+: 9.5;HEL: 3.7;U-87 MG: 3.8" HPA055927 Approved "Secreted in other tissues" NA NA "HPA055927: AB_2682972" "unprognostic (9.96e-2)" "unprognostic (4.30e-1)" "unprognostic (3.36e-2)" "unprognostic (5.63e-4)" "prognostic unfavorable (9.60e-4)" "unprognostic (1.66e-1)" "unprognostic (3.40e-2)" "unprognostic (1.13e-1)" "unprognostic (6.43e-2)" "unprognostic (1.32e-1)" "unprognostic (9.82e-2)" "unprognostic (2.51e-1)" "unprognostic (5.14e-6)" "unprognostic (2.10e-4)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (2.27e-1)" 0.1 19.6 0.4 0.1 0.0 0.0 0.3 5.2 0.4 0.1 0.0 0.0 0.1 0.9 0.2 0.4 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.4 3.9 0.6 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.0 1.2 0.0 0.0 8.8 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.2 0.0 0.0 0.6 0.8 0.2 9.5 0.7 0.6 0.0 0.3 0.0 0.1 0.1 0.7 0.0 0.1 0.5 0.4 1.6 0.3 3.7 0.0 0.1 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.5 0.0 0.2 0.0 0.4 0.4 0.4 0.1 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.3 0.6 0.1 0.0 1.1 0.0 1.4 1.3 0.2 0.5 0.1 0.0 0.0 3.8 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 44.6 0.4 0.0 0.0 0.0 0.0 64.8 0.0 0.0 0.3 8.1 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 10.5 0.3 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 17.9 0.0 0.1 0.6 0.9 0.0 0.1 0.0 0.0 0.0 FDCSP "C4orf7, FDC-SP" ENSG00000181617 "Follicular dendritic cell secreted protein" Q8NFU4 4 70226071-70235252 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "lymphoid tissue: 176.5;salivary gland: 452.5" "Cell type enriched" "Detected in single" 38 "Ductal cells: 37.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 336.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.2;GAMG: 10.9;HL-60: 2.0;RH-30: 3.0;U-87 MG: 8.0" "HPA014326, CAB014890" Enhanced "Secreted in other tissues" NA NA "CAB014890: , HPA014326: AB_1845719" "unprognostic (1.26e-3)" "unprognostic (2.32e-1)" "unprognostic (8.73e-3)" "unprognostic (9.62e-2)" "prognostic favorable (2.38e-4)" "unprognostic (5.99e-3)" "prognostic favorable (1.32e-4)" "unprognostic (2.04e-1)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (3.79e-1)" "unprognostic (1.96e-1)" "unprognostic (3.68e-2)" "unprognostic (2.80e-1)" "unprognostic (7.83e-2)" 0.4 0.4 0.4 95.4 0.4 0.0 9.7 0.4 0.4 0.4 1.0 0.0 0.0 0.0 0.4 0.0 1.9 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.5 124.7 0.4 0.0 0.4 0.4 0.0 0.4 0.0 0.0 0.4 0.7 0.0 452.5 0.0 0.5 0.4 3.7 0.0 0.4 12.1 0.4 0.4 0.0 0.4 0.5 35.9 176.5 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.2 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.1 0.0 0.0 0.0 0.2 8.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FTCDNL1 FONG ENSG00000226124 "Formiminotransferase cyclodeaminase N-terminal like" E5RQL4 2 199760544-199851173 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA065748 Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA065748: " "unprognostic (1.78e-1)" "unprognostic (1.70e-1)" "unprognostic (1.27e-2)" "unprognostic (9.80e-2)" "unprognostic (3.09e-1)" "unprognostic (7.21e-2)" "unprognostic (1.54e-3)" "unprognostic (1.59e-1)" "unprognostic (1.03e-1)" "unprognostic (4.82e-2)" "unprognostic (5.37e-2)" "unprognostic (9.86e-2)" "prognostic favorable (3.31e-4)" "unprognostic (3.92e-2)" "unprognostic (4.63e-2)" "prognostic unfavorable (5.74e-4)" "unprognostic (1.21e-2)" 4.5 9.4 5.5 1.8 19.0 4.0 4.2 1.6 12.0 1.7 2.3 9.7 2.6 2.1 1.2 3.9 2.9 3.9 2.0 5.3 5.8 4.8 8.0 17.9 2.8 3.5 7.6 7.5 2.4 4.3 1.9 2.0 1.5 7.9 2.8 2.5 2.7 4.8 1.7 13.1 2.4 1.8 3.4 9.1 8.0 2.1 2.8 4.0 0.1 11.0 2.4 1.8 1.6 1.9 3.8 10.6 2.0 6.2 1.2 2.4 1.9 0.7 2.4 0.1 0.1 2.5 1.5 1.8 0.9 0.9 1.2 0.5 0.0 4.3 2.4 0.3 1.0 7.2 0.0 1.1 6.4 1.5 2.9 0.8 1.8 1.0 2.0 0.9 6.4 8.1 1.1 0.2 0.5 0.1 0.9 0.0 6.1 3.4 0.1 0.9 7.4 2.4 2.6 2.0 0.6 5.1 0.4 0.2 0.1 0.5 0.0 2.9 0.0 4.2 3.9 4.0 1.8 6.0 8.5 0.7 3.5 0.0 2.2 1.5 6.5 3.5 1.4 6.5 3.3 1.7 0.0 5.3 2.0 0.6 6.2 2.3 3.8 2.2 0.8 6.9 2.1 1.5 2.4 0.0 1.2 5.6 10.6 0.0 1.9 5.5 19.0 1.6 12.0 5.8 4.8 7.6 7.5 7.9 4.0 0.0 0.0 0.5 2.3 2.4 3.3 4.5 5.1 0.0 2.3 3.5 3.9 1.1 1.7 0.2 1.6 1.1 0.0 0.0 0.6 1.2 1.4 1.8 0.0 5.8 7.0 1.6 0.0 2.5 6.2 0.8 0.3 4.3 6.8 1.0 0.6 0.9 0.5 0.0 0.4 8.7 5.4 0.0 3.6 0.5 0.7 1.9 0.2 0.0 0.9 0.7 GHRH GHRF ENSG00000118702 "Growth hormone releasing hormone" P01286 20 37251082-37261835 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 37.3" "Cell type enriched" "Detected in single" 4 "Cardiomyocytes: 1.1" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 8.5" "Region enriched" "Detected in some" 15 "hypothalamus: 37.3" "Cell type enhanced" "Detected in single" "eosinophil: 2.7" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "NTERA-2: 3.6;U-266/84: 12.7" "Region enriched" "Detected in some" 9 "hypothalamus: 38.7" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (4.78e-2)" "unprognostic (2.57e-2)" "unprognostic (1.58e-1)" "unprognostic (3.10e-1)" 0.1 2.7 0.3 0.1 2.4 0.0 0.6 0.1 1.0 0.1 4.0 0.1 0.1 8.1 0.1 0.1 0.7 0.0 0.1 6.5 0.1 37.3 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 7.7 0.1 0.1 0.1 1.9 0.1 0.1 7.5 0.4 0.1 0.1 0.1 0.1 0.0 0.7 2.7 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.4 0.1 1.0 0.1 37.3 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 HHIP "FLJ20992, HIP" ENSG00000164161 "Hedgehog interacting protein" Q96QV1 4 144646021-144745271 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.5;lung: 29.7" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 2: 177.0;Leydig cells: 126.0;Peritubular cells: 41.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.6" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 69.8;TIME: 80.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012616 Uncertain Approved Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "HPA012616: AB_1850687" "unprognostic (3.86e-2)" "unprognostic (1.19e-1)" "unprognostic (1.02e-2)" "unprognostic (7.12e-3)" "unprognostic (8.18e-2)" "unprognostic (2.43e-2)" "unprognostic (1.02e-1)" "unprognostic (3.60e-1)" "unprognostic (1.95e-2)" "unprognostic (4.20e-1)" "unprognostic (1.90e-2)" "unprognostic (1.89e-1)" "unprognostic (9.66e-3)" "unprognostic (7.13e-3)" "unprognostic (1.05e-1)" "unprognostic (5.18e-2)" "unprognostic (2.38e-1)" 4.0 5.2 9.9 1.7 22.2 2.3 1.1 2.3 16.0 3.4 6.5 31.5 0.0 5.5 4.1 8.1 1.0 1.2 3.0 1.1 16.0 6.3 2.4 12.7 29.7 1.0 21.6 9.9 2.2 4.8 1.0 1.1 1.0 17.5 9.8 6.8 4.4 1.3 6.2 1.3 1.1 8.2 1.3 12.3 1.0 11.2 3.7 26.5 2.3 1.6 0.0 1.0 7.1 1.0 0.1 2.6 0.5 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.7 3.8 69.8 6.2 0.0 0.0 1.0 0.0 9.8 0.0 0.9 0.0 0.6 0.1 14.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.5 0.0 0.8 0.0 0.5 0.4 0.0 2.1 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 2.6 0.0 0.0 9.9 22.2 2.3 16.0 16.0 6.3 21.6 9.9 17.5 26.5 11.9 177.0 0.0 0.0 0.0 1.4 1.1 0.0 8.1 6.8 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.0 0.4 0.0 16.1 0.0 0.1 0.0 0.0 16.0 0.0 1.8 126.0 1.0 1.7 0.0 0.0 0.2 0.1 0.0 41.4 0.0 3.5 0.0 0.4 0.2 0.2 0.5 0.0 0.0 0.0 0.0 HHIPL2 "FLJ13840, KIAA1822L" ENSG00000143512 "HHIP like 2" Q6UWX4 1 222522258-222548103 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 9.4;testis: 10.4;thyroid gland: 4.6" "Group enriched" "Detected in some" 9 "Early spermatids: 14.1;Late spermatids: 21.2;Spermatocytes: 8.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 16.2;Hep G2: 4.9;RH-30: 18.4;SuSa: 7.1;U-87 MG: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA059673 Enhanced Uncertain Mitochondria,Cytosol "Secreted in other tissues" No NA Mitochondria Cytosol "HPA059673: AB_2684100" "unprognostic (1.35e-2)" "unprognostic (4.62e-3)" "unprognostic (2.91e-1)" "unprognostic (9.21e-2)" "unprognostic (3.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.74e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.07e-2)" "unprognostic (3.64e-1)" "unprognostic (2.29e-2)" "unprognostic (2.14e-2)" "unprognostic (0.00e+0)" "unprognostic (6.52e-2)" "unprognostic (4.21e-4)" "unprognostic (2.30e-3)" "unprognostic (8.38e-2)" 0.3 0.7 0.0 0.1 0.6 0.1 0.2 0.1 1.4 0.7 0.0 0.6 0.0 0.0 0.1 0.5 0.5 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.9 9.4 0.2 0.3 1.9 3.9 0.0 0.1 0.1 0.0 0.0 0.1 0.1 10.4 0.0 0.0 4.6 0.0 0.3 0.2 0.7 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.1 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 16.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 4.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.3 0.0 18.4 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 7.1 0.0 0.0 0.0 0.8 0.2 0.0 0.2 0.0 0.1 0.0 9.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.1 1.4 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 1.7 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.4 0.5 0.0 0.0 0.0 0.0 0.0 IGFL1 UNQ644 ENSG00000188293 "IGF like family member 1" Q6UW32 19 46229752-46231243 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 51.5;tongue: 29.7" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 1.4;Suprabasal keratinocytes: 3.0" "Group enriched" "Detected in many" 7 "cervical cancer: 47.6;head and neck cancer: 60.7;melanoma: 23.3;urothelial cancer: 84.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HaCaT: 6.3;RT4: 23.4;SK-BR-3: 8.0" HPA014001 Uncertain "Secreted in other tissues" NA NA "HPA014001: AB_2668919" "unprognostic (1.35e-1)" "unprognostic (9.70e-2)" "unprognostic (2.89e-1)" "unprognostic (1.01e-1)" "unprognostic (1.64e-2)" "unprognostic (2.67e-2)" "unprognostic (3.06e-1)" "unprognostic (4.50e-3)" "unprognostic (6.70e-3)" "unprognostic (1.67e-1)" "unprognostic (1.80e-1)" "unprognostic (1.64e-1)" "unprognostic (3.23e-1)" 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.1 14.7 0.1 0.0 0.0 0.1 0.3 0.1 51.5 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.7 0.1 0.0 11.0 0.1 0.1 1.8 0.1 0.1 0.0 0.2 0.1 0.3 0.0 1.9 0.1 29.7 14.4 0.4 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 6.3 0.0 1.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.2 8.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.0 0.0 0.0 0.0 0.0 IGFL2 UNQ645 ENSG00000204866 "IGF like family member 2" Q6UWQ7 19 46143106-46161299 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "skin 1: 26.8;tongue: 24.8" "Cell type enhanced" "Detected in some" 8 "Early spermatids: 5.9;Late spermatids: 3.9;Spermatocytes: 8.0;Spermatogonia: 7.0;Suprabasal keratinocytes: 4.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "memory CD4 T-cell: 2.4" "Lineage enriched" "Detected in single" 24 "T-cells: 2.4" "Group enriched" "Detected in some" 64 "CACO-2: 28.9;OE19: 58.1" HPA059137 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in other tissues" NA NA Nucleoplasm "Plasma membrane" "HPA059137: AB_2683920" "unprognostic (1.53e-1)" "unprognostic (7.87e-2)" "unprognostic (1.64e-1)" "unprognostic (1.69e-2)" "unprognostic (7.30e-2)" "unprognostic (9.74e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (1.68e-1)" "unprognostic (4.26e-3)" "unprognostic (9.63e-3)" "unprognostic (4.14e-9)" "unprognostic (1.27e-1)" "unprognostic (2.76e-2)" "unprognostic (8.73e-2)" "unprognostic (9.91e-3)" 1.5 0.0 0.4 0.1 0.1 0.0 1.8 0.1 0.4 0.3 0.3 0.1 0.1 0.0 0.1 0.5 1.0 0.0 0.1 1.1 0.1 0.1 0.1 0.1 0.8 1.2 0.4 0.1 0.1 0.1 3.4 0.1 1.6 0.9 0.1 0.7 0.1 0.5 0.1 0.1 26.8 0.1 0.1 0.3 0.1 0.0 2.4 0.1 0.4 0.1 24.8 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.1 0.4 0.1 0.9 0.1 0.0 0.0 0.0 0.0 1.9 1.9 0.4 0.0 0.0 1.2 0.0 0.0 3.2 0.0 0.0 5.9 0.0 0.5 0.0 0.2 0.1 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 1.7 0.0 0.2 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.4 8.0 7.0 4.1 2.2 0.0 1.3 0.0 IGFL3 UNQ483 ENSG00000188624 "IGF like family member 3" Q6UXB1 19 46120071-46124674 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 22.4" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 2.7;Exocrine glandular cells: 5.9;Melanocytes: 1.7;Suprabasal keratinocytes: 6.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 5.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.3;CACO-2: 2.2;hTEC/SVTERT24-B: 2.8;U-2 OS: 3.0;U-87 MG: 5.6" HPA062776 Uncertain "Secreted in other tissues" NA NA "HPA062776: AB_2684866" "unprognostic (8.61e-2)" "unprognostic (6.26e-2)" "unprognostic (2.69e-1)" "unprognostic (4.78e-2)" "unprognostic (7.45e-3)" "unprognostic (2.03e-1)" "unprognostic (7.90e-2)" "unprognostic (1.90e-1)" "unprognostic (1.86e-4)" "unprognostic (2.86e-2)" "unprognostic (1.90e-1)" "unprognostic (3.69e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 2.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 22.4 0.1 0.1 0.1 0.1 0.0 2.9 0.1 1.9 0.1 2.7 0.1 0.1 0.1 1.5 0.2 0.0 0.2 0.0 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.3 0.6 0.5 2.2 0.3 0.0 0.4 0.0 0.3 0.1 0.0 0.0 1.5 0.3 0.0 0.0 0.6 0.3 0.0 0.0 0.1 1.2 0.5 2.8 0.3 1.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.0 0.0 0.1 0.7 0.0 0.2 5.6 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.6 0.6 0.1 0.2 0.2 1.5 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 ISM1 "bA149I18.1, C20orf82" ENSG00000101230 "Isthmin 1" B1AKI9 20 13221771-13300651 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 33.8" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 4.0;Fibroblasts: 8.1;Proximal tubular cells: 3.1;Suprabasal keratinocytes: 2.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 4.0;naive CD4 T-cell: 3.3" "Lineage enriched" "Detected in single" 40 "T-cells: 4.0" "Group enriched" "Detected in some" 5 "ASC diff: 36.3;Hep G2: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (7.13e-2)" "unprognostic (3.55e-1)" "unprognostic (4.43e-3)" "unprognostic (5.27e-3)" "unprognostic (1.84e-2)" "unprognostic (5.56e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (2.06e-1)" "unprognostic (4.48e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (9.32e-6)" "unprognostic (2.58e-2)" "unprognostic (2.10e-1)" "unprognostic (6.83e-2)" "unprognostic (1.81e-2)" 7.8 2.4 0.8 0.5 1.1 0.0 17.0 0.7 1.5 2.4 2.1 0.8 2.0 0.3 1.8 2.3 4.5 2.3 4.4 2.2 1.0 1.7 2.4 4.5 3.2 1.0 0.7 0.9 1.1 5.7 0.1 1.0 12.7 1.3 1.9 0.2 0.8 8.9 0.7 2.3 9.2 1.1 1.7 0.6 4.8 1.9 1.2 0.8 1.4 33.8 5.5 1.1 3.8 6.1 0.0 0.0 0.0 0.0 0.0 4.0 1.5 0.0 0.3 0.2 0.5 36.3 5.1 0.2 0.3 3.0 0.0 0.0 2.0 0.3 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 2.9 0.0 0.0 13.9 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.2 0.0 0.3 0.3 0.0 0.2 1.1 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 1.0 0.1 0.7 0.0 0.0 0.0 2.1 0.3 0.1 0.2 0.0 3.4 0.6 0.0 1.6 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.4 0.0 0.0 3.3 0.5 0.0 0.0 0.0 0.0 0.0 1.5 0.8 1.1 0.7 1.5 1.0 1.7 0.7 0.9 1.3 0.8 0.0 0.3 0.0 0.5 4.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 2.3 0.0 0.0 0.0 0.2 8.1 0.1 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.8 0.0 0.2 2.5 0.6 0.5 0.0 0.1 KCP "CRIM2, FLJ33365, NET67" ENSG00000135253 "Kielin/chordin-like protein" 7 128862451-128910719 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "ductus deferens: 30.0;kidney: 11.2;seminal vesicle: 28.3" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 50.6;Early spermatids: 18.3;Late spermatids: 21.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.7;HMC-1: 7.7;U-87 MG: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (6.12e-2)" "unprognostic (5.49e-2)" "unprognostic (1.45e-3)" "unprognostic (6.33e-3)" "unprognostic (2.14e-1)" "unprognostic (5.24e-3)" "unprognostic (2.01e-3)" "unprognostic (3.25e-3)" "unprognostic (9.59e-2)" "unprognostic (1.52e-1)" "unprognostic (2.20e-3)" "unprognostic (6.46e-2)" "unprognostic (1.93e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (4.84e-2)" "unprognostic (7.64e-3)" 2.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 30.0 0.9 0.1 1.7 0.4 0.6 2.1 0.3 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 1.3 0.0 0.1 0.1 28.3 0.0 0.0 2.1 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 13.7 0.2 2.1 0.0 0.3 1.0 0.0 0.0 0.0 1.9 0.1 1.0 0.0 1.2 0.2 0.0 7.7 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.1 0.6 0.1 0.0 1.8 0.5 0.0 0.0 0.0 0.0 0.4 0.1 0.8 0.9 0.4 0.0 0.0 0.1 0.2 0.0 0.3 0.3 0.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 4.3 0.8 1.1 0.0 2.5 0.8 0.0 0.0 6.8 50.6 2.0 0.2 0.0 0.2 18.3 0.3 5.9 0.0 0.2 1.0 1.1 0.3 2.3 0.2 1.0 3.2 2.4 2.5 2.2 21.8 1.1 2.3 0.0 0.0 3.1 0.2 2.5 1.9 0.4 2.9 1.0 0.0 0.0 5.1 2.4 0.0 1.1 1.9 6.4 3.6 LCN15 "PRO6093, UNQ2541" ENSG00000177984 "Lipocalin 15" Q6UWW0 9 136759634-136766255 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 4.9;ductus deferens: 12.0;intestine: 16.5;seminal vesicle: 5.3" "Cell type enriched" "Detected in some" 54 "Intestinal endocrine cells: 377.4" "Cancer enriched" "Detected in some" 19 "colorectal cancer: 23.0" "Group enriched" "Detected in some" 6 "amygdala: 2.4;cerebral cortex: 4.9;hippocampal formation: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "Hep G2: 19.7" "Low region specificity" "Detected in all" HPA060584 Enhanced "Secreted in other tissues" NA NA "HPA060584: AB_2684327" "unprognostic (5.24e-1)" "unprognostic (2.61e-1)" "unprognostic (2.14e-1)" "unprognostic (3.67e-1)" "unprognostic (3.45e-2)" "unprognostic (3.28e-2)" "unprognostic (2.39e-1)" "unprognostic (1.83e-1)" 0.1 0.0 2.4 0.1 0.4 0.0 0.1 0.1 4.9 0.1 12.8 0.1 12.0 16.5 0.1 2.0 0.1 0.0 0.1 1.9 1.7 0.1 0.1 0.1 2.0 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 2.6 0.1 0.1 5.3 1.3 0.0 5.2 0.1 0.7 0.3 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.4 0.1 4.9 1.7 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 377.4 0.0 0.8 1.7 0.0 0.0 1.7 0.0 0.7 0.0 0.0 7.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.3 LYPD6 MGC52057 ENSG00000187123 "LY6/PLAUR domain containing 6" Q86Y78 2 149329985-149474148 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 17.7;placenta: 22.7" "Group enriched" "Detected in many" 33 "Early spermatids: 54.3;Late spermatids: 174.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 18.6;fHDF/TERT166: 23.9;HBF TERT88: 13.1;LHCN-M2: 23.7;RT4: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042805 Enhanced Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA042805: AB_10794159" "unprognostic (1.77e-1)" "unprognostic (1.01e-1)" "unprognostic (7.23e-3)" "unprognostic (1.64e-2)" "unprognostic (3.25e-1)" "unprognostic (6.49e-3)" "unprognostic (6.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.73e-2)" "prognostic favorable (3.59e-4)" "unprognostic (4.14e-3)" "unprognostic (6.75e-2)" "unprognostic (7.33e-4)" "unprognostic (1.39e-1)" "unprognostic (1.94e-1)" "unprognostic (1.09e-1)" "prognostic favorable (2.72e-4)" 2.6 1.0 8.7 1.8 7.9 0.4 14.6 3.3 8.2 2.0 4.4 4.3 1.1 2.8 4.0 1.0 1.2 2.9 17.7 1.4 6.2 11.5 3.4 0.8 1.3 0.8 6.2 5.3 1.4 3.2 2.6 0.9 22.7 7.2 2.5 4.1 2.8 0.8 2.6 0.7 1.4 5.6 4.7 5.1 1.3 6.2 4.5 2.6 0.0 0.6 0.0 2.3 4.4 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.5 18.6 0.0 0.0 0.2 7.6 3.3 9.6 6.1 0.1 1.5 0.0 0.4 23.9 4.7 1.9 2.7 0.0 13.1 0.0 0.9 0.0 4.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 5.8 0.1 0.1 0.0 0.0 0.0 23.7 3.0 0.0 1.7 2.7 1.6 2.2 0.0 10.3 0.0 1.2 19.5 0.7 3.4 5.1 5.8 0.6 6.3 0.7 0.3 0.0 0.2 3.0 0.2 4.1 0.0 0.0 0.0 1.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 8.7 7.9 3.3 8.2 6.2 11.5 6.2 5.3 7.2 2.6 0.0 0.0 0.0 0.5 0.1 1.9 0.3 2.5 1.4 3.4 0.0 0.0 0.0 3.3 2.2 54.3 0.2 1.0 0.0 0.7 0.2 0.4 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 174.5 2.8 0.0 0.0 0.0 2.5 3.5 3.3 0.0 0.4 0.0 3.2 0.0 0.1 0.7 1.1 0.0 0.2 0.0 1.9 1.1 MAMDC2 MGC21981 ENSG00000165072 "MAM domain containing 2" Q7Z304 9 70043581-70226970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 37.9;Leydig cells: 89.5;Peritubular cells: 77.1;Sertoli cells: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 4 "NK-cell: 2.6" "Lineage enriched" "Detected in single" 4 "NK-cells: 2.6" "Cell line enhanced" "Detected in some" "ASC diff: 23.0;HHSteC: 24.0;LHCN-M2: 29.9;TIME: 28.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021814, HPA022249" Uncertain Approved "Nuclear speckles,Plasma membrane" "Secreted in other tissues" NA NA "Nuclear speckles, Plasma membrane" "HPA021814: AB_1853508, HPA022249: AB_2139157" "unprognostic (1.88e-1)" "unprognostic (3.16e-3)" "unprognostic (2.21e-3)" "unprognostic (2.71e-2)" "unprognostic (4.30e-2)" "unprognostic (8.49e-2)" "unprognostic (1.27e-2)" "unprognostic (8.25e-2)" "unprognostic (5.91e-2)" "unprognostic (3.65e-2)" "unprognostic (1.92e-1)" "unprognostic (3.67e-1)" "unprognostic (3.03e-2)" "unprognostic (4.23e-3)" "unprognostic (2.35e-1)" "prognostic unfavorable (7.78e-4)" "unprognostic (2.79e-3)" 9.0 4.3 0.6 11.1 0.5 0.0 14.7 0.6 0.8 32.3 27.7 0.3 9.1 4.3 40.7 33.7 31.6 28.7 44.9 13.5 0.6 0.6 2.0 1.0 42.4 2.3 0.7 0.8 35.5 2.4 1.0 0.8 2.6 1.3 13.9 6.6 16.1 5.4 10.8 15.5 5.0 14.2 46.3 2.6 12.0 10.7 20.0 0.0 0.3 6.8 24.6 6.1 36.4 27.5 0.0 0.3 0.0 0.0 2.6 0.6 0.0 0.1 0.0 0.2 0.0 23.0 7.8 0.7 4.5 2.0 1.0 1.9 0.0 0.5 0.0 0.3 0.8 0.6 3.6 0.0 0.3 0.9 0.0 0.0 0.0 7.4 0.0 24.0 0.0 0.0 1.4 0.2 0.6 0.4 8.2 1.9 0.0 0.0 0.2 29.9 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.6 2.8 10.1 0.0 0.3 0.0 0.0 0.0 0.0 8.9 0.0 0.0 28.7 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.6 0.5 0.6 0.8 0.6 0.6 0.7 0.8 1.3 0.0 0.0 1.0 0.0 0.4 5.5 0.4 3.1 0.0 0.0 0.0 3.5 3.9 0.1 0.0 0.0 37.9 2.9 0.0 0.0 0.2 5.7 21.0 0.1 1.1 0.0 2.6 0.0 0.0 0.0 0.0 9.1 89.5 0.7 10.1 0.0 0.0 15.4 0.3 0.0 77.1 0.3 0.2 38.8 25.0 0.3 0.4 4.3 0.2 0.0 0.0 0.0 MUC1 "ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM" ENSG00000185499 "Mucin 1, cell surface associated" P15941 1 155185824-155192916 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 168.1;kidney: 158.5;lung: 143.5" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 1308.2;Collecting duct cells: 465.9;Exocrine glandular cells: 994.6;Pancreatic endocrine cells: 807.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 4.0" "Group enriched" "Detected in many" 10 "granulocytes: 1.3;T-cells: 4.0" "Group enriched" "Detected in many" 6 "CAPAN-2: 139.4;OE19: 65.3;RPTEC TERT1: 107.0;T-47d: 47.0" "CAB000036, CAB001986, HPA004179, HPA007235, HPA008855" Enhanced Supported "Plasma membrane" "Secreted in other tissues" NA NA 4900000 "Plasma membrane" "CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283" "unprognostic (4.74e-2)" "unprognostic (2.84e-2)" "unprognostic (2.19e-1)" "unprognostic (8.01e-2)" "unprognostic (1.32e-2)" "unprognostic (1.70e-1)" "unprognostic (2.61e-3)" "unprognostic (6.34e-2)" "unprognostic (1.43e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (4.60e-4)" "unprognostic (4.75e-1)" "unprognostic (2.05e-2)" "unprognostic (1.13e-1)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (1.21e-1)" 1.5 0.7 0.8 12.6 1.2 0.9 12.6 0.4 0.7 31.6 15.9 1.2 2.4 2.9 10.5 9.8 51.8 18.7 168.1 0.8 0.5 0.3 158.5 2.0 143.5 0.3 0.5 0.3 14.9 74.2 0.0 4.7 15.5 2.1 6.1 16.1 0.8 17.0 5.9 0.8 1.8 3.6 2.8 0.7 0.6 105.0 4.3 0.5 0.7 15.7 10.5 47.8 12.3 5.2 0.0 0.2 1.3 0.1 0.0 4.0 0.2 1.8 0.9 0.6 0.5 0.4 0.5 0.2 0.6 1.4 0.7 1.9 0.0 139.4 0.0 10.1 1.1 0.3 2.8 0.1 0.0 0.2 1.2 0.1 0.2 11.8 0.0 0.3 0.0 4.4 1.2 0.2 0.3 0.2 1.5 0.2 0.2 1.0 1.9 0.5 14.2 0.1 0.1 0.4 65.3 0.2 0.2 0.0 3.4 107.0 0.1 0.6 0.2 3.3 5.9 0.1 0.5 47.0 0.6 0.2 0.4 0.8 1.3 0.1 2.1 1.1 0.0 0.7 0.1 0.1 1.3 0.1 0.0 0.0 0.0 0.8 0.0 2.3 0.4 0.2 0.0 0.3 0.7 0.0 0.0 0.0 0.0 4.0 0.2 0.8 1.2 0.4 0.7 0.5 0.3 0.5 0.3 2.1 0.5 402.0 1308.2 0.9 16.1 0.6 1.0 0.4 384.7 92.3 252.5 465.9 3.9 0.1 29.9 144.7 27.3 3.5 49.2 0.0 994.6 1.2 3.1 11.6 45.2 0.5 0.2 1.6 29.4 1.3 3.4 68.9 2.3 2.6 5.0 42.3 249.7 1.1 807.2 66.2 1.4 0.9 0.2 0.0 1.9 6.2 0.8 1.0 0.2 0.0 132.5 164.3 MUC16 "CA125, FLJ14303" ENSG00000181143 "Mucin 16, cell surface associated" Q8WXI7 19 8848844-8981342 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adipose tissue: 6.6;cervix, uterine: 19.3;fallopian tube: 6.7;salivary gland: 6.3" "Cell type enhanced" "Detected in some" 27 "Ciliated cells: 49.5;Club cells: 10.3;Early spermatids: 11.7;Late spermatids: 12.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 21.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 15.9;CAPAN-2: 5.6;HaCaT: 5.4;HeLa: 27.6;SK-BR-3: 3.5" "CAB055172, HPA065600" Enhanced "Secreted in other tissues" NA NA "CAB055172: AB_2148831, HPA065600: AB_2732736" "unprognostic (8.66e-2)" "unprognostic (3.89e-2)" "unprognostic (5.37e-2)" "unprognostic (3.07e-1)" "unprognostic (1.76e-2)" "unprognostic (3.01e-3)" "unprognostic (3.83e-3)" "unprognostic (1.31e-2)" "unprognostic (1.00e-2)" "unprognostic (1.86e-1)" "unprognostic (1.89e-3)" "unprognostic (1.81e-1)" "unprognostic (2.60e-8)" "unprognostic (3.50e-2)" "unprognostic (2.86e-1)" "unprognostic (1.43e-1)" "unprognostic (3.68e-3)" 6.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 19.3 0.0 0.0 2.4 0.0 0.2 6.7 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.4 2.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 2.2 0.0 49.5 10.3 0.0 0.0 1.4 0.0 0.2 11.7 0.0 0.0 0.0 0.0 0.7 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 2.7 0.0 0.0 0.6 MUC5B "MG1, MUC5" ENSG00000117983 "Mucin 5B, oligomeric mucus/gel-forming" Q9HC84 11 1223066-1262172 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 301.7;lymphoid tissue: 155.1;salivary gland: 192.8" "Cell type enriched" "Detected in some" 4 "Cholangiocytes: 591.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "OE19: 41.8;PC-3: 45.1" "HPA008246, CAB009396" Enhanced Supported Vesicles "Secreted in other tissues" NA NA 590000 Vesicles "CAB009396: AB_2282256, HPA008246: AB_1854203" "unprognostic (2.01e-2)" "unprognostic (1.46e-1)" "unprognostic (9.39e-2)" "unprognostic (2.76e-3)" "unprognostic (5.46e-2)" "unprognostic (1.22e-1)" "unprognostic (4.89e-2)" "unprognostic (7.80e-3)" "unprognostic (3.75e-1)" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (8.95e-2)" "unprognostic (2.57e-7)" "unprognostic (2.71e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (8.13e-2)" 0.1 0.1 0.1 0.7 0.1 0.0 0.2 0.1 0.1 67.4 8.4 0.0 0.0 0.0 1.9 0.0 11.6 0.2 301.7 0.1 0.1 0.1 0.1 0.6 2.0 0.0 0.1 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.1 4.6 0.0 192.8 0.0 0.7 0.1 0.3 0.1 0.1 0.1 1.5 0.1 0.0 0.0 0.1 31.6 155.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 41.8 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 32.8 0.9 0.0 0.0 0.0 10.5 591.1 34.8 46.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.1 0.0 1.2 4.6 0.0 0.2 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.1 0.0 0.5 48.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 131.5 0.3 MUCL1 SBEM ENSG00000172551 "Mucin like 1" Q96DR8 12 54830519-54858393 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 75 "breast: 283.5;salivary gland: 277.2;skin 1: 99.4" "Cell type enriched" "Detected in some" 6 "Melanocytes: 1005.5" "Cancer enriched" "Detected in many" 30 "breast cancer: 298.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.5;memory CD8 T-cell: 1.1;naive CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 2.0;hTCEpi: 2.2;MCF7: 3.7;SK-BR-3: 9.2;SuSa: 6.2" HPA039093 Enhanced "Secreted in other tissues" NA NA "HPA039093: AB_10795577" "unprognostic (2.26e-1)" "unprognostic (3.38e-1)" "unprognostic (1.90e-1)" "unprognostic (1.47e-1)" "unprognostic (2.53e-1)" "unprognostic (8.34e-3)" "unprognostic (5.55e-2)" "unprognostic (2.00e-1)" "unprognostic (3.11e-2)" "unprognostic (2.31e-2)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (4.04e-1)" "unprognostic (9.90e-2)" 2.9 0.0 0.1 0.1 0.1 0.0 283.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.1 0.0 0.1 277.2 0.1 0.2 99.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 9.2 0.0 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 1.1 0.0 0.0 0.0 1.1 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.4 167.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1005.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.8 0.0 0.0 0.0 0.6 NBL1 "D1S1733E, DAN, DAND1, NB, NO3" ENSG00000158747 "Neuroblastoma 1, DAN family BMP antagonist" P41271 1 19596979-19658456 "Predicted intracellular proteins, Predicted secreted proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 363.8;Leydig cells: 358.1;Peritubular cells: 335.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 3.5" "Lineage enriched" "Detected in single" 5 "T-cells: 3.5" "Cell line enhanced" "Detected in many" "ASC diff: 74.3;HSkMC: 52.6;SK-MEL-30: 77.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007394, CAB026132" Uncertain "Secreted in other tissues" NA NA 10000000 "CAB026132: , HPA007394: AB_10601272" "unprognostic (1.65e-1)" "unprognostic (1.65e-2)" "unprognostic (9.03e-2)" "unprognostic (2.85e-1)" "unprognostic (1.33e-2)" "unprognostic (1.93e-1)" "unprognostic (1.18e-2)" "unprognostic (3.15e-2)" "unprognostic (3.92e-1)" "unprognostic (7.88e-2)" "unprognostic (3.10e-2)" "unprognostic (1.92e-2)" "unprognostic (1.39e-2)" "unprognostic (1.46e-1)" "unprognostic (2.39e-1)" "unprognostic (6.21e-2)" "unprognostic (2.26e-2)" 27.5 8.7 20.7 16.8 23.1 1.9 38.7 8.1 31.3 109.5 77.8 8.9 13.5 54.6 45.7 21.7 49.0 41.2 58.0 31.1 22.2 15.1 17.4 8.4 47.5 13.7 14.3 23.6 133.7 10.0 16.2 22.2 8.2 15.8 67.5 31.6 23.6 11.2 35.0 18.3 32.4 86.3 43.1 13.6 8.3 25.2 23.9 11.8 6.3 15.2 25.4 14.0 44.6 65.9 0.2 0.1 0.5 0.2 0.7 3.5 0.5 22.2 7.0 1.2 6.4 74.3 38.7 3.3 32.0 39.9 10.8 11.0 1.9 40.3 0.0 20.5 40.2 7.6 25.1 6.7 29.7 3.3 21.1 3.5 1.1 6.9 11.6 12.0 0.0 0.5 52.6 27.3 15.9 9.8 3.2 8.1 1.3 0.2 0.0 3.4 3.2 0.0 1.8 0.4 23.1 10.5 1.0 0.0 0.7 20.6 2.7 0.5 17.2 5.1 0.2 77.3 1.2 26.7 3.9 11.3 10.6 8.4 30.2 4.9 0.1 0.1 0.1 7.7 0.1 3.1 0.0 0.2 0.5 0.4 0.1 1.7 0.1 3.5 1.8 0.1 0.2 2.5 1.6 0.1 0.7 0.2 0.1 0.0 0.5 20.7 23.1 8.1 31.3 22.2 15.1 14.3 23.6 15.8 11.8 3.0 2.9 2.7 208.3 155.1 16.7 26.2 48.4 6.7 5.7 34.9 5.9 0.6 3.3 40.2 1.6 105.9 363.8 0.0 6.8 1.9 174.7 257.9 13.8 0.5 41.1 6.4 52.4 30.7 1.8 4.5 358.1 6.0 57.3 10.0 184.7 5.7 58.7 179.9 335.6 16.7 8.1 129.4 194.2 1.2 3.6 177.0 1.1 10.7 166.9 177.6 OC90 PLA2L ENSG00000253117 "Otoconin 90" Q02509 8 132024220-132059380 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.5;lymphoid tissue: 1.1;placenta: 1.3;retina: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 47 "SK-MEL-30: 4.7" "Secreted in other tissues" NA NA "unprognostic (1.92e-1)" "unprognostic (2.93e-1)" 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.2 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ODAPH "AI2A4, C4orf26, FLJ23657" ENSG00000174792 "Odontogenesis associated phosphoprotein" Q17RF5 4 75556048-75565885 "Disease related genes, Predicted secreted proteins" "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 10.4;placenta: 34.3" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 6.2;Syncytiotrophoblasts: 22.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.1" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 20 "basophil: 10.4" "Lineage enriched" "Detected in single" 24 "granulocytes: 10.4" "Cell line enriched" "Detected in some" 5 "HDLM-2: 31.1" "Secreted in other tissues" NA NA "unprognostic (1.13e-1)" "unprognostic (4.45e-3)" "unprognostic (3.78e-1)" "unprognostic (1.66e-1)" "unprognostic (6.12e-2)" "unprognostic (2.12e-2)" "unprognostic (1.75e-2)" "unprognostic (2.44e-1)" "unprognostic (3.87e-2)" "unprognostic (5.30e-2)" "unprognostic (3.43e-1)" "unprognostic (1.17e-7)" "unprognostic (8.31e-2)" "unprognostic (2.70e-2)" "unprognostic (8.40e-4)" "unprognostic (6.53e-3)" 0.3 0.1 1.5 0.4 1.9 0.6 0.2 1.2 0.9 0.3 0.2 0.2 0.2 0.1 0.3 0.4 0.4 0.1 0.3 0.2 1.9 1.5 0.3 0.4 0.3 0.5 2.4 0.2 0.4 0.2 0.0 1.3 34.3 0.7 0.2 0.5 0.2 0.2 0.3 1.6 0.9 0.3 0.2 2.7 0.4 0.3 0.8 0.4 0.2 0.2 0.2 0.7 0.2 0.2 0.4 0.1 10.4 0.2 0.2 0.3 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 31.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 1.4 0.0 1.3 0.1 0.1 0.0 0.0 1.4 0.1 0.4 5.6 0.0 0.1 0.3 0.2 0.0 10.4 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.1 1.5 1.9 1.2 0.9 1.9 1.5 2.4 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 6.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 OLFM2 "NOE2, OlfC" ENSG00000105088 "Olfactomedin 2" O95897 19 9853718-9936552 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.4;skin 1: 60.2" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 111.0;Late spermatids: 38.1;Muller glia cells: 72.1;Suprabasal keratinocytes: 103.3" "Cancer enhanced" "Detected in all" "glioma: 96.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 24.9" "Group enriched" "Detected in many" 27 "granulocytes: 24.9;T-cells: 8.9" "Cell line enhanced" "Detected in many" "AN3-CA: 15.7;ASC diff: 14.9;BJ hTERT+: 11.3;SH-SY5Y: 15.2;U-2 OS: 18.2;WM-115: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049961, HPA057771" Uncertain Approved Nucleoplasm "Secreted in other tissues" NA NA 2300000 Nucleoplasm "HPA049961: AB_2680972, HPA057771: AB_2683524" "unprognostic (1.42e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.99e-2)" "unprognostic (5.91e-2)" "unprognostic (3.39e-2)" "unprognostic (8.78e-2)" "unprognostic (4.47e-2)" "unprognostic (8.04e-2)" "unprognostic (4.03e-2)" "unprognostic (1.41e-3)" "unprognostic (2.77e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.23e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-2)" "unprognostic (1.23e-1)" 20.9 12.2 37.2 2.7 39.7 0.8 5.8 9.1 51.4 4.5 1.9 11.6 0.3 2.1 7.9 3.8 3.9 6.6 4.9 3.9 26.2 21.6 1.8 23.5 3.2 5.0 19.6 17.9 3.5 7.9 1.1 4.4 5.2 15.4 5.2 1.4 3.2 7.1 10.3 1.7 60.2 2.0 5.1 9.0 2.2 1.4 5.2 4.6 16.0 8.4 1.1 3.7 2.6 3.2 0.0 0.0 24.9 0.0 0.6 8.9 1.7 0.0 2.2 1.8 15.7 14.9 9.2 1.0 3.4 11.3 0.8 0.9 0.1 1.5 0.0 1.4 2.5 1.3 0.9 6.0 1.0 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.0 2.7 4.8 0.9 0.1 0.1 0.4 0.0 2.9 0.1 0.2 0.0 4.9 0.1 0.1 9.7 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.1 15.2 0.6 0.0 3.1 6.3 0.6 0.0 0.1 6.6 18.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 15.7 9.6 0.0 24.9 3.5 0.0 3.8 0.0 4.1 3.1 0.0 0.0 8.0 5.1 0.3 0.6 0.0 0.0 8.9 1.7 37.2 39.7 9.1 38.0 26.2 21.6 19.6 17.9 15.4 4.6 0.0 0.0 0.0 4.6 111.0 2.9 0.6 5.1 0.0 0.0 7.0 0.0 0.1 1.7 0.6 6.8 0.5 0.0 0.0 2.0 0.0 9.6 5.0 4.6 16.1 0.2 1.6 1.2 0.6 0.3 38.1 12.7 0.3 16.9 0.0 0.0 72.1 6.6 0.0 9.2 0.0 2.5 0.0 18.7 2.1 9.3 103.3 0.1 7.5 0.0 2.3 OPTC ENSG00000188770 Opticin Q9UBM4 1 203494143-203508864 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 92 "retina: 245.8" "Cell type enriched" "Detected in single" 6 "Spermatocytes: 1.4" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.0;HeLa: 1.4;hTERT-RPE1: 1.3;NTERA-2: 2.4;RT4: 1.5;SCLC-21H: 1.2;SuSa: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA034951, HPA034952" Enhanced "Secreted in other tissues" NA NA "HPA034951: AB_10669852, HPA034952: AB_2674379" "unprognostic (3.29e-1)" "unprognostic (1.56e-1)" "unprognostic (7.69e-2)" "unprognostic (3.19e-2)" "unprognostic (1.70e-3)" "unprognostic (8.24e-2)" "unprognostic (3.65e-2)" 0.3 0.0 0.2 0.1 0.2 0.0 0.2 0.4 1.0 0.4 1.3 0.1 0.1 0.4 1.3 2.2 0.8 0.8 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 1.1 0.3 0.0 0.1 0.4 0.1 0.7 0.3 245.8 0.1 0.6 0.1 1.1 0.2 1.1 0.1 0.1 0.1 2.6 0.1 0.1 0.2 0.1 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.1 1.0 0.3 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.7 0.0 0.1 0.0 0.0 1.5 1.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.9 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 OTOG "FLJ46346, mlemp, OTGN" ENSG00000188162 Otogelin Q6ZRI0 11 17547373-17647150 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "pituitary gland: 4.8;testis: 3.5" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 10.1;Late spermatids: 21.0;Muller glia cells: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "CACO-2: 14.4" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.25e-2)" "unprognostic (1.19e-1)" "unprognostic (6.95e-3)" "unprognostic (1.85e-6)" "unprognostic (1.89e-1)" "unprognostic (3.60e-1)" "unprognostic (5.14e-5)" "unprognostic (1.78e-1)" "unprognostic (8.97e-2)" "unprognostic (1.57e-2)" "unprognostic (4.72e-5)" "unprognostic (5.55e-2)" "unprognostic (1.48e-1)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.1 0.0 0.0 0.0 0.0 OTOL1 "C1QTNF15, C1QTNF16" ENSG00000182447 "Otolin 1" A6NHN0 3 161496808-161503942 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 8 "brain: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA041030 Uncertain "Secreted in other tissues" NA NA "HPA041030: AB_10795000" 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTOR "FDP, MIAL, MIAL1" ENSG00000125879 Otoraplin Q9NRC9 20 16748358-16770062 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.3;stomach 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 17.0" "Not detected" "Not detected" HPA024335 Uncertain "Secreted in other tissues" NA NA "HPA024335: AB_1854838" "unprognostic (8.50e-3)" "unprognostic (9.56e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-1)" "unprognostic (1.72e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 17.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTOS OTOSP ENSG00000178602 Otospiralin Q8NHW6 2 240139026-240144562 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "pituitary gland: 39.1;thyroid gland: 41.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "glioma: 6.5;thyroid cancer: 28.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.1;hTEC/SVTERT24-B: 1.8;U-138 MG: 2.2" "Region enriched" "Detected in single" 4 "hippocampal formation: 1.8" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (8.52e-2)" "unprognostic (1.73e-1)" "unprognostic (9.01e-3)" "unprognostic (1.35e-1)" "unprognostic (2.72e-1)" "unprognostic (3.27e-3)" 0.3 0.3 4.5 0.3 4.6 0.3 0.4 0.3 3.8 0.5 0.3 0.7 0.0 0.3 0.4 0.7 0.3 0.4 0.3 0.3 2.4 1.1 0.3 0.3 0.3 0.3 0.6 2.0 0.3 0.3 0.3 39.1 0.3 5.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.8 0.3 0.3 0.4 0.8 0.0 41.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.9 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.2 0.7 0.0 0.5 0.0 0.1 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 4.6 0.3 3.8 2.4 1.1 0.6 2.0 5.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PEBP4 "CORK1, hPEBP4, MGC22776" ENSG00000134020 "Phosphatidylethanolamine binding protein 4" Q96S96 8 22713251-23000000 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 85.8;skeletal muscle: 124.6" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 101.3;Alveolar cells type 2: 146.5;Cardiomyocytes: 105.2;Muller glia cells: 177.5" "Group enriched" "Detected in many" 13 "lung cancer: 11.4;prostate cancer: 23.7;thyroid cancer: 35.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.7;neutrophil: 2.7;NK-cell: 2.6" "Group enriched" "Detected in many" 19 "B-cells: 2.7;granulocytes: 2.7;NK-cells: 2.6" "Cell line enriched" "Detected in some" 6 "U-266/70: 9.5" HPA025064 Uncertain "Secreted in other tissues" NA NA 200000000 "HPA025064: AB_1855174" "unprognostic (1.34e-2)" "unprognostic (2.97e-2)" "unprognostic (4.11e-2)" "unprognostic (3.66e-1)" "unprognostic (3.35e-1)" "unprognostic (4.78e-2)" "unprognostic (1.66e-4)" "unprognostic (1.18e-2)" "unprognostic (2.60e-1)" "unprognostic (1.74e-1)" "unprognostic (3.90e-2)" "unprognostic (8.76e-3)" "unprognostic (9.70e-8)" "unprognostic (1.13e-2)" "unprognostic (2.56e-1)" "unprognostic (3.48e-1)" "unprognostic (4.59e-1)" 2.7 0.9 2.2 0.2 4.9 0.2 0.9 1.0 1.9 0.3 0.2 2.4 0.8 0.1 0.3 85.8 1.6 0.5 0.6 43.8 2.2 5.1 0.6 0.7 31.8 0.3 10.8 0.8 0.4 7.4 0.4 4.7 0.2 7.8 10.4 0.2 18.9 12.3 0.8 124.6 0.3 0.2 0.2 1.0 0.2 1.7 1.4 2.5 0.0 22.3 16.6 2.3 0.2 0.0 2.7 0.1 2.7 0.0 2.6 0.1 0.0 0.0 0.0 0.1 0.1 0.5 0.7 0.1 0.0 0.7 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.9 0.1 0.0 0.2 0.0 0.0 1.5 0.1 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.5 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.4 0.0 0.0 2.7 2.6 0.0 0.1 0.0 0.0 2.2 4.9 1.0 1.9 2.2 5.1 10.8 0.8 7.8 2.5 101.3 146.5 0.0 0.9 1.6 10.4 105.2 0.0 5.3 13.6 1.8 2.0 0.6 3.3 0.0 27.5 2.1 0.0 0.0 8.3 0.1 1.0 11.1 7.0 0.6 1.1 9.5 0.0 3.1 0.0 19.3 3.1 1.1 1.7 0.0 0.0 177.5 0.3 0.0 10.3 1.8 7.3 0.0 3.1 2.2 0.7 0.6 0.0 0.7 0.0 0.9 PRG3 "MBP2, MBPH" ENSG00000156575 "Proteoglycan 3, pro eosinophil major basic protein 2" Q9Y2Y8 11 57376769-57381150 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "bone marrow: 31.6;lymphoid tissue: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 48 "HMC-1: 68.2" "Not detected" "Not detected" HPA064183 Enhanced "Secreted in other tissues" NA NA 240000 "HPA064183: AB_2685205" 0.1 0.0 0.0 0.0 0.0 31.6 0.1 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 68.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSORS1C2 "C6orf17, SPR1" ENSG00000204538 "Psoriasis susceptibility 1 candidate 2" Q9UIG4 6 31137536-31139350 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 13.8;skin 1: 58.0;tongue: 35.9" "Group enriched" "Detected in some" 15 "Melanocytes: 8.5;Suprabasal keratinocytes: 6.0" "Cancer enhanced" "Detected in many" "urothelial cancer: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.1;HaCaT: 1.6;SiHa: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA061228 Enhanced "Secreted in other tissues" NA NA "HPA061228: AB_2684455" "unprognostic (8.86e-2)" "unprognostic (7.73e-2)" "unprognostic (1.52e-1)" "unprognostic (5.67e-2)" "unprognostic (5.20e-3)" "unprognostic (1.67e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-2)" "unprognostic (3.78e-1)" "unprognostic (1.64e-2)" "unprognostic (1.06e-1)" "unprognostic (9.40e-5)" "unprognostic (2.09e-1)" "unprognostic (1.61e-1)" "unprognostic (1.50e-1)" "unprognostic (2.66e-1)" 0.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 58.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 13.8 0.0 35.9 0.7 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.6 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.5 RTBDN FLJ36353 ENSG00000132026 Retbindin Q9BSG5 19 12825478-12835428 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 17.3;pituitary gland: 25.8;retina: 57.0" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 329.9;Rod photoreceptor cells: 289.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 1.7;neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SCLC-21H: 8.2;SH-SY5Y: 5.4;U-266/84: 21.1;U-87 MG: 4.8" "Not detected" "Not detected" HPA052511 Approved "Endoplasmic reticulum" "Secreted in other tissues" NA NA "Endoplasmic reticulum" "HPA052511: AB_2797243" "unprognostic (4.55e-4)" "unprognostic (3.94e-3)" "unprognostic (2.18e-1)" "unprognostic (1.54e-4)" "unprognostic (3.33e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" "unprognostic (2.45e-2)" "unprognostic (2.02e-2)" "unprognostic (3.55e-1)" "unprognostic (6.48e-2)" "unprognostic (7.04e-3)" "unprognostic (7.66e-9)" "unprognostic (3.55e-2)" "unprognostic (1.00e-1)" "unprognostic (7.05e-2)" "unprognostic (2.24e-2)" 0.3 6.9 10.2 0.5 3.4 0.9 0.3 2.7 17.3 0.2 0.9 0.4 0.0 1.0 0.3 1.5 0.3 0.3 0.4 0.3 7.3 5.1 0.2 0.4 0.5 0.4 2.8 2.8 0.3 2.5 0.2 25.8 0.3 4.0 0.4 0.9 57.0 0.3 0.3 0.3 0.5 1.0 0.6 1.0 0.4 2.5 3.5 0.0 7.0 0.4 0.0 0.4 0.3 0.0 0.3 0.2 1.8 0.2 0.4 0.2 0.0 0.9 0.1 0.1 0.6 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.3 0.1 0.9 0.9 0.0 0.6 0.2 0.3 0.0 0.0 0.1 0.1 0.0 0.4 0.9 0.0 0.1 2.4 0.0 0.0 0.4 0.2 0.0 0.0 0.1 1.2 2.7 0.0 0.1 0.0 0.0 0.9 0.7 1.1 0.7 0.1 1.0 0.0 0.0 8.2 5.4 0.1 0.1 0.4 0.4 2.7 0.7 0.0 0.8 1.0 0.7 0.1 1.2 21.1 4.0 4.8 0.0 0.0 1.7 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.2 1.8 0.4 0.2 0.2 0.1 0.0 10.2 3.4 2.7 8.6 7.3 5.1 2.8 2.8 4.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 1.4 0.0 0.0 0.0 0.0 329.9 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 45.9 0.1 0.0 0.0 0.0 289.4 0.0 0.0 11.5 5.1 0.0 0.0 0.0 0.0 0.0 S100A7 "PSOR1, S100A7c" ENSG00000143556 "S100 calcium binding protein A7" P31151 1 153457744-153460701 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 116.2;lymphoid tissue: 156.7;tongue: 409.9" "Group enriched" "Detected in some" 5 "Suprabasal keratinocytes: 78.3;Syncytiotrophoblasts: 22.1" "Group enriched" "Detected in many" 5 "cervical cancer: 458.9;head and neck cancer: 1201.5;melanoma: 638.4;urothelial cancer: 281.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 7.4;SK-BR-3: 17.3" "CAB001453, HPA006997, CAB033766" Enhanced Uncertain Cytosol "Secreted in other tissues" NA NA 17000000 Cytosol "CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860" "unprognostic (3.28e-1)" "unprognostic (9.85e-2)" "unprognostic (1.32e-2)" "unprognostic (2.16e-2)" "unprognostic (3.17e-1)" "unprognostic (2.94e-2)" "unprognostic (1.03e-2)" "unprognostic (4.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.27e-1)" "unprognostic (2.99e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 2.2 0.1 0.1 45.2 0.1 0.1 0.1 0.0 3.7 3.9 116.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 6.2 0.1 0.1 45.7 0.1 0.2 0.1 0.1 0.0 0.3 0.1 1.2 0.1 409.9 156.7 0.2 85.3 0.0 0.4 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 7.4 0.0 2.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.5 0.0 0.2 0.0 0.2 0.0 0.0 0.7 0.2 0.4 0.0 0.0 0.0 0.8 17.3 0.0 1.1 0.3 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 78.3 22.1 0.0 0.0 0.4 SCGB1D1 "LIPA, LPHA, MGC71958" ENSG00000168515 "Secretoglobin family 1D member 1" O95968 11 62190216-62193539 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 5.4;fallopian tube: 3.2;lymphoid tissue: 2.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 40 "endometrial cancer: 23.3;ovarian cancer: 16.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "SCLC-21H: 11.9" "Secreted in other tissues" NA NA "unprognostic (6.95e-3)" "unprognostic (9.01e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 5.4 0.1 0.1 0.1 0.0 1.1 0.1 1.4 3.2 0.1 0.1 0.1 0.8 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.1 2.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCGB1D2 "LIPB, LPHB" ENSG00000124935 "Secretoglobin family 1D member 2" O95969 11 62242210-62244808 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 101.5;cervix, uterine: 315.2" "Cell type enriched" "Detected in some" 25 "Melanocytes: 781.1" "Group enriched" "Detected in many" 6 "breast cancer: 625.1;endometrial cancer: 226.0" "Region enriched" "Detected in some" 6 "pons and medulla: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 14.7" HPA035318 Approved "Secreted in other tissues" NA NA "HPA035318: AB_10610421" "unprognostic (8.76e-2)" "unprognostic (2.14e-1)" "prognostic favorable (3.46e-6)" "unprognostic (2.39e-2)" "unprognostic (5.89e-2)" "unprognostic (4.72e-2)" "unprognostic (1.99e-1)" "unprognostic (6.43e-2)" "prognostic favorable (8.03e-6)" "unprognostic (1.55e-1)" "unprognostic (1.15e-2)" 1.8 0.4 0.8 0.2 0.6 0.0 101.5 0.9 0.5 315.2 0.2 0.9 6.2 0.0 18.4 43.8 0.8 8.5 0.4 1.0 1.2 0.4 1.1 0.2 0.2 0.2 1.0 0.5 1.1 2.9 0.0 1.0 0.6 7.3 1.1 0.0 1.2 9.5 0.5 2.4 59.6 0.2 0.2 0.4 0.2 0.0 1.6 0.5 0.2 0.3 2.1 1.2 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.7 0.2 0.0 2.5 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.9 0.5 1.2 0.4 1.0 0.5 7.3 0.5 0.0 0.0 0.0 5.0 24.4 0.5 6.5 0.0 0.0 0.0 7.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 31.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 781.1 0.0 0.0 17.0 0.0 0.0 0.0 13.2 0.6 0.0 0.3 0.0 0.0 6.0 0.1 0.0 0.0 1.0 SCGB2A1 "LPHC, MGB2, MGC71973, UGB3" ENSG00000124939 "Secretoglobin family 2A member 1" O75556 11 62208668-62213939 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix, uterine: 191.8;epididymis: 135.9" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 61.1;Ciliated cells: 107.1;Glandular cells: 36.8;Intestinal endocrine cells: 35.6;Mucus-secreting cells: 60.0" "Group enriched" "Detected in many" 10 "endometrial cancer: 971.9;ovarian cancer: 208.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "EFO-21: 14.0" HPA034584 Enhanced Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA034584: AB_10602221" "unprognostic (7.73e-2)" "unprognostic (3.77e-1)" "prognostic favorable (1.22e-4)" "prognostic favorable (1.54e-8)" "unprognostic (2.98e-2)" "unprognostic (1.86e-2)" "unprognostic (3.39e-1)" "unprognostic (1.95e-1)" "unprognostic (2.69e-1)" "unprognostic (6.87e-3)" "prognostic favorable (6.36e-4)" "unprognostic (5.67e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-3)" "unprognostic (3.35e-1)" 0.2 0.0 0.2 0.5 0.2 0.0 6.8 0.2 0.3 191.8 1.0 0.3 20.8 0.0 40.8 135.9 1.0 28.7 2.5 0.4 0.2 0.3 1.2 0.4 0.9 0.2 0.2 0.3 5.6 2.2 0.0 1.5 0.7 0.5 1.2 1.3 0.2 18.8 1.4 0.2 2.3 0.3 0.2 0.2 0.2 4.3 4.5 0.2 0.3 0.8 1.1 3.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.5 0.0 0.1 0.0 1.1 0.2 0.0 2.6 0.6 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.3 0.5 0.2 0.0 3.7 0.0 4.1 0.1 0.0 0.0 61.1 107.1 11.4 15.7 0.0 0.1 3.3 4.8 0.0 0.0 2.6 0.0 4.7 0.0 0.0 36.8 0.0 0.0 3.7 0.0 35.6 0.0 0.0 0.0 0.0 0.0 5.0 0.0 60.0 0.0 14.5 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.4 3.9 SCGB3A2 "LU103, PNSP1, UGRP1" ENSG00000164265 "Secretoglobin family 3A member 2" Q96PL1 5 147870682-147882191 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lung: 248.0" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 3186.5;Club cells: 12064.6" "Cancer enriched" "Detected in some" 10 "lung cancer: 211.2" "Region enriched" "Detected in single" 7 "pons and medulla: 1.0" "Cell type enriched" "Detected in single" 40 "basophil: 30.1" "Lineage enriched" "Detected in single" 40 "granulocytes: 30.1" "Cell line enhanced" "Detected in some" "A-431: 22.2;EFO-21: 13.9;NTERA-2: 15.9;PC-3: 78.6;SuSa: 33.3" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (3.85e-1)" "unprognostic (1.77e-1)" "unprognostic (2.99e-2)" "unprognostic (3.51e-2)" "unprognostic (1.84e-2)" "unprognostic (3.17e-2)" "unprognostic (1.05e-2)" "unprognostic (1.90e-8)" "unprognostic (9.31e-3)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (9.11e-2)" 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 248.0 0.1 0.1 0.1 0.1 0.3 0.0 0.6 0.1 1.0 0.1 0.0 0.1 1.7 0.4 0.1 0.4 0.1 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.7 0.2 0.2 0.1 0.1 0.2 0.3 30.1 0.5 0.7 0.2 0.0 22.2 0.3 0.3 0.5 0.3 0.1 0.6 0.3 0.0 0.0 0.0 0.1 0.3 0.1 13.9 0.0 0.2 0.2 0.6 0.3 0.1 0.0 0.4 0.8 2.4 0.0 0.0 0.1 0.8 0.3 0.2 0.1 0.0 0.5 0.0 0.0 0.6 0.3 0.0 0.4 0.2 0.2 15.9 0.0 78.6 0.0 0.2 0.0 0.3 0.1 1.1 0.3 3.1 0.3 0.0 33.3 0.3 0.1 0.4 0.3 9.3 0.4 0.3 0.4 0.3 0.1 0.1 0.3 1.0 30.1 0.5 0.1 0.2 0.3 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.1 0.1 0.7 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.1 574.7 3186.5 0.0 0.0 0.0 0.0 0.0 0.0 1145.6 12064.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 97.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 SFN YWHAS ENSG00000175793 Stratifin P31947 1 26863138-26864457 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 6884.3;Suprabasal keratinocytes: 9365.4;Urothelial cells: 2426.4" "Cancer enhanced" "Detected in all" "head and neck cancer: 2526.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "basophil: 7.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.1" "Cell line enhanced" "Detected in many" "A-431: 70.1;HaCaT: 110.7;HBEC3-KT: 170.4;hTCEpi: 114.4" "Low region specificity" "Detected in some" "CAB006268, HPA011105, CAB040552, HPA061603" Enhanced Supported "Nucleoli rim,Cytosol" "Secreted in other tissues" NA NA 54000000 Cytosol "Nucleoli rim" "CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: " "unprognostic (5.70e-2)" "unprognostic (1.26e-1)" "unprognostic (8.37e-2)" "prognostic favorable (1.92e-4)" "unprognostic (1.26e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (5.68e-5)" "unprognostic (1.71e-2)" "unprognostic (2.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavorable (6.01e-4)" "unprognostic (3.83e-1)" "prognostic unfavorable (7.45e-6)" "unprognostic (7.90e-3)" "unprognostic (3.25e-1)" "unprognostic (8.12e-2)" "unprognostic (2.06e-2)" 0.4 0.0 0.5 3.1 0.5 0.0 3.8 0.4 0.7 37.5 10.7 0.5 0.5 5.9 3.3 0.7 256.2 0.0 6.0 0.3 0.6 0.1 1.2 0.5 8.2 0.3 0.4 0.3 0.3 0.3 0.0 0.3 3.4 0.8 5.9 4.0 0.3 25.5 0.4 0.4 123.8 13.2 0.5 0.7 0.3 6.6 0.4 0.4 3.1 0.4 256.0 107.4 9.1 47.7 0.0 0.0 7.1 0.0 0.0 0.6 0.0 70.1 11.8 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 4.3 37.1 0.6 3.1 0.0 0.0 110.7 0.0 170.4 0.0 16.7 0.5 0.0 11.8 12.5 0.0 0.0 0.1 0.0 114.4 0.0 29.9 0.0 0.0 0.0 0.1 0.4 0.0 15.0 0.0 0.0 0.2 12.2 19.7 0.0 0.0 3.9 26.5 16.2 0.0 0.0 16.9 3.0 0.1 0.2 7.9 0.1 0.0 0.0 32.4 0.0 0.4 0.1 0.5 0.3 0.1 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.5 0.5 0.4 0.7 0.6 0.1 0.4 0.3 0.8 0.4 166.7 216.2 0.5 1339.8 6884.3 0.0 0.3 33.1 30.8 122.8 15.7 0.0 6.7 3.3 52.1 0.0 0.6 409.5 0.0 68.0 45.3 37.0 487.4 31.2 0.0 1.6 0.0 64.7 0.6 0.3 0.0 0.0 15.6 506.2 1.8 78.2 0.0 315.2 136.8 0.0 0.0 0.0 0.0 110.7 0.0 0.2 9365.4 5.0 0.0 146.1 2426.4 SFTA2 SFTPG ENSG00000196260 "Surfactant associated 2" Q6UW10 6 30931353-30955636 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lung: 104.5" "Group enriched" "Detected in many" 7 "Alveolar cells type 1: 497.3;Alveolar cells type 2: 624.9;Cholangiocytes: 170.7;Club cells: 204.8" "Cancer enhanced" "Detected in many" "lung cancer: 121.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 11 "B-cells: 1.7;T-cells: 1.7" "Group enriched" "Detected in some" 5 "CACO-2: 13.8;CAPAN-2: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (5.82e-2)" "unprognostic (1.16e-1)" "unprognostic (7.20e-3)" "unprognostic (6.64e-2)" "unprognostic (3.12e-1)" "unprognostic (1.34e-1)" "unprognostic (6.37e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (1.16e-1)" "unprognostic (3.96e-4)" "unprognostic (8.84e-2)" "unprognostic (2.36e-2)" "unprognostic (5.39e-3)" "unprognostic (7.95e-2)" 0.1 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.1 1.2 0.1 0.1 0.5 0.0 0.2 0.1 13.6 1.4 6.3 0.2 0.1 0.0 1.6 0.1 104.5 0.1 0.1 0.1 0.3 1.1 0.4 0.1 0.6 0.2 0.2 0.0 0.1 1.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 2.0 1.3 0.1 0.1 1.0 0.4 0.3 0.1 5.4 1.7 0.1 0.1 0.0 0.0 1.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 7.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 1.5 0.5 0.1 1.7 1.3 1.7 0.1 0.0 0.0 0.0 0.4 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 497.3 624.9 0.0 0.1 0.1 0.4 0.0 170.7 14.7 204.8 50.6 0.0 0.0 3.3 18.0 2.9 0.7 0.0 0.0 32.4 0.0 0.2 0.3 11.6 0.0 0.1 0.0 0.0 0.0 0.0 7.4 0.3 0.2 0.0 0.0 0.0 1.1 57.0 0.0 0.4 0.3 0.0 0.0 0.0 6.2 0.9 0.0 0.0 0.0 0.0 1.3 SFTA3 "NANCI, SFTPH" ENSG00000229415 "Surfactant associated 3" P0C7M3 14 36473288-36513829 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "lung: 45.2;thyroid gland: 55.4" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 321.6;Alveolar cells type 2: 451.3;Club cells: 171.8" "Group enriched" "Detected in some" 238 "lung cancer: 18.4;thyroid cancer: 52.8" "Region enhanced" "Detected in single" "basal ganglia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 173 "SCLC-21H: 21.5" "Secreted in other tissues" NA NA "prognostic favorable (8.29e-4)" "unprognostic (3.95e-1)" "unprognostic (3.21e-3)" 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 55.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.1 321.6 451.3 0.0 0.0 0.0 0.0 0.0 0.0 53.5 171.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.9 0.0 0.0 0.0 0.0 0.0 SLURP2 ENSG00000283992 "Secreted LY6/PLAUR domain containing 2" P0DP57 8 142764338-142769844 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 112.1;lymphoid tissue: 60.7;tongue: 105.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HaCaT: 24.7" "Secreted in other tissues" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.8 0.0 112.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 24.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 105.8 60.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.1 5.5 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPARCL1 MAST9 ENSG00000152583 "SPARC like 1" Q14515 4 87473335-87531061 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 20 "Endothelial cells: 1521.8;Peritubular cells: 2372.1;Sertoli cells: 4598.4" "Cancer enhanced" "Detected in all" "glioma: 528.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 17.8;SuSa: 25.3;U-266/70: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB026225 Enhanced "Secreted in other tissues" NA NA 660000000 "CAB026225: " "unprognostic (1.02e-2)" "unprognostic (2.81e-2)" "prognostic unfavorable (4.06e-4)" "unprognostic (1.19e-1)" "unprognostic (1.79e-2)" "unprognostic (4.93e-2)" "unprognostic (1.63e-3)" "unprognostic (1.73e-2)" "unprognostic (3.88e-2)" "unprognostic (6.04e-2)" "unprognostic (1.28e-1)" "unprognostic (1.17e-1)" "unprognostic (2.45e-3)" "unprognostic (1.76e-2)" "unprognostic (5.72e-2)" "unprognostic (2.88e-3)" "prognostic unfavorable (3.33e-4)" 102.2 21.9 110.3 18.8 139.9 0.9 52.1 42.9 212.1 123.2 58.0 17.9 23.8 19.7 148.7 74.6 56.4 92.8 74.7 80.9 98.8 40.9 13.2 4.5 58.7 14.6 67.5 106.4 45.2 13.0 15.8 38.3 48.8 69.7 97.0 30.4 7.9 31.5 166.0 35.2 13.1 27.4 185.6 82.5 23.9 40.8 29.2 53.9 1.2 38.8 24.4 15.6 103.9 50.3 0.0 0.3 0.1 0.1 0.0 0.8 0.0 0.5 0.0 17.8 0.2 0.1 0.1 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 1.0 1.9 0.0 0.0 1.4 0.0 0.2 0.8 0.3 0.8 0.2 1.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.6 0.0 0.4 0.1 2.7 0.4 0.0 0.0 0.2 0.3 0.8 0.0 0.1 0.6 1.4 0.1 0.1 0.1 25.3 0.3 0.3 0.0 0.2 0.2 1.0 0.1 7.0 0.9 0.4 2.7 0.3 2.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.1 0.3 0.0 0.0 110.3 139.9 42.9 136.4 98.8 40.9 67.5 106.4 69.7 53.9 11.9 84.8 13.7 145.4 41.1 7.3 256.0 2.5 13.4 79.6 7.0 2.0 1.7 11.6 0.5 9.5 1521.8 0.0 0.0 0.4 4.4 128.5 36.6 7.0 7.4 8.4 3.2 0.0 459.7 4.1 21.4 610.7 30.6 54.0 0.0 0.0 177.6 0.1 0.0 2372.1 11.0 29.9 4598.4 816.1 4.7 6.6 34.9 2.1 4.9 0.0 107.5 TECTB ENSG00000119913 "Tectorin beta" Q96PL2 10 112283400-112305035 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "retina: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Hep G2: 7.4;U-2197: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted in other tissues" NA NA "unprognostic (3.14e-2)" "unprognostic (2.84e-2)" "unprognostic (9.75e-3)" "unprognostic (1.65e-1)" "unprognostic (1.32e-2)" "unprognostic (5.54e-2)" "unprognostic (2.80e-2)" "unprognostic (8.10e-2)" 0.1 0.0 0.8 0.1 1.3 0.0 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.1 3.5 0.1 0.0 0.1 0.1 0.4 0.2 0.1 2.4 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 15.8 0.1 0.1 0.1 0.0 0.3 0.1 0.5 0.1 0.0 0.2 0.1 0.1 1.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.1 0.3 0.4 0.2 0.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 UMOD ENSG00000169344 Uromodulin P07911 16 20333052-20356301 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Ciliopathy, Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 417 "kidney: 237.4" "Group enriched" "Detected in some" 383 "Collecting duct cells: 235.5;Distal tubular cells: 805.7" "Cancer enriched" "Detected in single" 39 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "EFO-21: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009446, HPA043420, HPA054721" Enhanced "Secreted in other tissues" NA NA 55000000 83000000 "CAB009446: AB_2212378, HPA043420: AB_2678474, HPA054721: AB_2682585" "unprognostic (2.51e-2)" "unprognostic (1.33e-1)" "unprognostic (6.45e-2)" "unprognostic (3.02e-2)" "unprognostic (1.49e-2)" "unprognostic (1.43e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 237.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 235.5 0.0 0.0 805.7 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0